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CLINICAL AND FUNCTIONAL ASSESSMENT FOLLOWING AUTOLOGOUS
CHONDROCYTE IMPLANTATION TO THE KNEE:
THE ROLE OF PATIENT REPORTED OUTCOMES, PERFORMANCE BASED
ASSESSMENT, AND RESPONSE SHIFT
Autologous chondrocyte implantation (ACI) is a cell based therapy for the
treatment of articular cartilage defects. Numerous studies have reported outcomes
following ACI using a variety of patient reported outcomes (PROs), but no clear
recommendations exist regarding which PRO is the most responsive to changes following
ACI. Few studies have documented changes in performance based assessments (PBAs)
following ACI. Response shift theory proposes that residual changes in self-report
measures occur over time. Failing to account for response shift may result in over or
under reporting of outcomes from which clinical decisions are made. The purposes of this
dissertation were 1) review the literature concerning ACI outcomes to determine the
responsiveness of PROs to changes in self-reported function following ACI, 2) evaluate
the reliability of PBAs among ACI patients, 3) develop a descriptive timeline for the
return of function 1 year following ACI using both PROs and PBAs, and 4) utilize PROs
and PBAs to evaluate patients undergoing ACI for evidence of response shift.
All PRO and PBA measures were collected preoperatively and 3, 6, and 12
months postoperatively. A retrospective then-test PRO evaluation of function prior to
surgery was completed at 6 and 12 months. Response shift was calculated by subtracting
the original pre-test score from the then-test score.
A systematic review and meta-analyses of existing ACI outcome studies resulted
in the recommendation of the International Knee Documentation Committee Subjective
Knee Form (IKDC) and Lysholm Knee Scale as highly responsive PROs among ACI
patients of varying activity levels. Despite significant increases in PRO scores as early as
6 months following ACI, improvement in PBAs at 12 months following ACI were limited
to stride length, walking speed, and step-up force. Finally, no evidence of a group level
effect for response shift was observed. These results support the validity of traditional
pre-test/post-test research designs with no need to account for response shift when
evaluating treatment effects of ACI on the group level. However, the Western Ontario

and McMasters University Osteoarthritis Index (WOMAC) did show evidence of a
measurable response shift on a patient by patient basis.
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CHAPTER 1: INTRODUCTION AND SYSTEMATIC REVIEW AND METAANALYSIS OF PATIENT REPORTED OUTCOME INSTRUMENTS FOLLOWING
AUTOLOGOUS CHONDROCYTE IMPLANTATION
Articular cartilage defects of the knee are a complex and challenging pathology
with limited options for treatment and clinical management.

The poor healing of these

defects has been documented for over 200 years,75 and when left untreated can progress to
osteoarthritis.99 Defects have been observed to occur in 63% of all knee arthroscopies,39
and may be associated with trauma or be idiopathic in nature. One report observed
defects present in 16 to 46% of ACL reconstructions.30 If not treated appropriately
defects to the articular cartilage can become increasingly painful and disabling. This is
particularly true for lesions of the knee where biomechanical stresses result in both shear
and compressive forces during normal activities of daily living.
Treatment of articular cartilage injuries represents a complex and challenging
problem for both orthopedic surgeons and rehabilitation specialists. Treatment options for
articular cartilage defects can range from simple debridement to marrow stimulating
techniques or more complex auto- and allograft treatments. One emerging form of
treatment is cell based therapies. These treatments are based on the implantation of
chondrocytes into the symptomatic defect. The use of autologous chondrocyte
implantation/transplantation (ACI or ACT) in a human population was first reported in
1994.28 The ACI procedure involves a two step surgical process. During the first surgery
a biopsy of healthy chondrocytes is obtained from a low weight bearing portion of the
knee such as the intracondylar notch. These cells are then cultured and expanded in a
laboratory and then transplanted into the defect in a second surgery. The original
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procedure called for cells to be transplanted under a periosteom flap harvested from the
patient during the second surgery.28 The procedure has since been modified to commonly
use a porcine type I/III collagen membrane to cover the defect in place of the periosteal
flap (ACI-C).21, 59, 92 In some regions the seeding of chondrocytes on a porcine type I/III
collagen bilayer matrix (MACI) prior to implantation has also been introduced into
practice as the third generation of the ACI procedure.13, 35

PURPOSE
For each generation of ACI introduced, numerous reports of treatment outcomes
have been presented. However these outcomes have focused primarily on patient
reported outcomes (PROs) and disease oriented outcomes such as magnetic resonance
imaging (MRI) or tissue biopsy. Very few investigators have documented ACI outcomes
using performance based assessments (PBAs). PBAs provide a direct, objective measure
of patient function that can be combined with PROs to form a full picture of clinical
outcomes following treatment without regard for the biologic outcome that is assessed by
MRI or tissue biopsy. This study was an investigation of clinical and functional outcomes
following ACI to the knee and the methodology for documenting those outcomes. The
primary purposes of this dissertation were the following:
1. To systematically review and evaluate via meta-analysis the responsiveness of
common instruments used to measure PROs following ACI at varying time points.
Hypothesis: All instruments will demonstrate improved self-reported function and
health related quality of life following ACI with the simplest instruments showing the
greatest treatment effect.
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2. To determine among articular cartilage patients the reliability of the following
NeuroCom Balance Master® long force plate assessments: Walk Across, Weight
Bearing Squat, Unilateral Stance, Sit-to-Stand, Step Up/Over, and Forward Lunge
tests. Hypotheses: The reliability of all measures of time, distance, and force will
demonstrate acceptable ICC values>0.75. There will be poor reliability of measures
of sway and balance with ICC values <0.75.
3. To document the clinical outcomes of ACI patients over one year following surgery
utilizing both patient reported outcomes (PROs) and performance based assessments
(PBAs), and to examine the relationship between PROs and PBAs. Hypotheses: All
PROs and PBAs will demonstrate an initial decrease in function at the three month
time point. There will be improved function at 6 months and improvements from
baseline at the 12 month time point based on PRO and PBA evaluations.
4. To determine if patients undergoing ACI experience a response shift between
preoperative assessment and evaluation at 6 and 12 months postoperative.
Hypotheses: There will be evidence of a response shift as assessed via PROs.
Further evidence of this response shift will be supported by changes in the
relationship between PROs and PBAs over time.

OVERVIEW
This dissertation is organized according to the following: Chapter 1 consists of a
systematic review of the use of PROs to document patient outcomes following ACI. This
chapter will provide a historical context of the use of PROs and treatment outcomes
following ACI. Chapter 2 presents the reliability of a series of PBAs utilizing the
NeuroCom Balance Master® long force plate in an ACI patient population. Reliability
was evaluated both preoperatively and 12 months following ACI to determine the
3

reliability of the chosen measures across time points. Chapter 3 reports PRO and PBA
outcomes prior to ACI and at 3 months, 6 months and 12 months following ACI. This
information will provide a time line for recovery and return of function following ACI.
Chapter 4 investigates the evidence of a response shift phenomenon influencing PROs
following ACI. The relationship between PROs and PBAs across time will be examined
in an attempt to validate the occurrence of a response shift. Chapter 5 will summarize the
results of all portions of this dissertation and interpret these finding for future research
and clinical application.

OPERATIONAL DEFINITIONS
Autologous Chondrocyte Implantation (ACI):
Two stage, cell based surgical therapy for the treatment of articular cartilage
defects. Stage one involves the biopsying of healthy articular cartilage from a non-or
low-weight bearing portion of the knee. This cartilage is then cultured and expanded, and
these chondrocytes are transplanted into the defect during a second surgery.

Patient Reported Outcome (PRO):
Self report questionnaires or instruments intended to document the patients’
perspective of their level of function and/or health related quality of life.

Performance Based Assessment (PBA):
Form of an objective evaluation requiring physical or mental function, ability, or
competence of a task that is typically measured in a quantifiable variable such as time,
speed, force, distance, or errors.
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Response Shift:
A residual change in perception that occurs over time and can affect PROs based on
the patient’s internal frame of reference pre- or post-intervention. These changes are due
to recalibration, reconceptualization, and reprioritization of internal standards and
references utilized for self-appraisal.

ASSUMPTIONS
The primary assumptions of this dissertation were the following;
1. Subjects provide honest answers and best effort when completing PROs
and PBAs.
2. Subjects clearly understood and followed instructions for both PROs and
PBAs.
3. Changes in PBAs were related to changes in knee health and not other,
unknown, unreported, underlying conditions.
4. All patients were compliant with activity restrictions and rehabilitation
protocols.

DELIMITATIONS
1. For the meta-analysis portion of this dissertation, only those studies presenting
statistics from which effect sizes could be calculated were be included.
2. For the meta-analysis portion of this dissertation only those studies reporting
PROs using the Medical Outcomes Study 36-Item Short Form Health Survey
Physical Component Scale (SF-36 PCS), the International Knee
Documentation Committee Subjective Knee Form (IKDC), the Lysholm Knee
Scale (Lysholm), the modified Cincinnati Knee Rating System (MCKRS), the
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Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC),
or the Knee Injury and Osteoarthritis Outcome Score (KOOS) were included
3. All surgeries were performed by a single surgeon and all patients were
recruited from a single practice.
4. All physical therapy was completed in individual outpatient clinical settings
and was not directly supervised or controlled.
5. No direct measures of cartilage healing such as MRI or tissue biopsy were
utilized in this study.
6. All patients undergoing ACI regardless of defect locations or the occurrence of
realignment procedures have been included
7. Previous injury or surgery was not controlled for.
8. The “then-test” method was used to test for response shift among ACI
patients, and this method may be susceptible to recall bias.

LIMITATIONS
1. A number of patients (n=5) were lost to follow-up during the course of this
study. Despite multiple attempts to contact these patients complete data for
these patients could not be obtained and is therefore missing from the
presented results.
2. A number of patients (n=6) were declared clinical failures during the course of
this study and either underwent surgical revision prior to study completion or
performance testing was contraindicated by the treating physician. When
possible data from these patients were included in the results of this study.
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SYSTEMATIC REVIEW AND META-ANALYSIS OF PATIENT REPORTED
OUTCOME INSTRUMENTS FOLLOWING AUTOLOGOUS CHONDROCYTE
IMPLANTATION

Introduction
The limited ability of articular cartilage to heal on its own has been a topic of
discussion for over 200 years.75 The treatment and management of articular cartilage
damage can be particularly challenging in the knee joint where such defects have been
frequently observed during arthroscopic surgery. 30, 39, 68, 182

Restorative and reparative

treatment of these defects, whether they penetrate to the subchondral bone (osteochondral
lesions) or remain limited to the cartilage surface (chondral lesions), is highly desirable to
prevent the progression of osteoarthritis.99

Autologous Chondrocyte Implantation
Over the last three decades, approaches to treating chondral defects have shifted
towards cell based therapies. These therapies have focused predominantly on the
implantation of autologous chondrocytes directly into pathologic defects. The first
published reports of human outcomes following autologous chondrocyte implantation
were presented in 1994.28 As originally described, autologous chondrocyte implantation/
transplantation (ACI or ACT) is a two stage treatment where a cartilage biopsy is taken in
one surgery and during a later surgery cultured chondrocytes are implanted into the
defect.28 Due to complications with graft hypertrophy considered to be linked to the use
of the periosteal flap used to cover the defect and to reduce concomitant trauma, the
procedure has since been modified to commonly use a porcine type I/III collagen
membrane to cover the defect in place of the periosteal flap (ACI-C).21, 59, 92 In efforts to
further advance the procedure, a third generation of ACI involves the seeding of
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chondrocytes on a porcine type I/III collagen bilayer matrix (MACI) prior to
implantation.13, 35 Finally, the 4th generation of ACI to become commercially available is
characterized chondrocyte implantation (CCI).152 This method involves the use of a gene
marker profile to determine the cartilage forming potential of cells to selectively choose
cells for expansion and implantation.

Treatment Evaluation
As new methods for treating cartilage are developed it is necessary to evaluate
these treatments to determine their effectiveness. While second look arthroscopies with
cartilage biopsies provide the most diagnostic method of evaluating cartilage repair, they
are not always feasible or ethical to perform. In addition, biopsies allow for the
assessment of the histological tissue repair, but they cannot be used to evaluate patient
oriented outcomes such as pain and function. To evaluate patient oriented outcomes
researchers and clinicians have relied on patient reported outcome instruments (PROs).
Numerous PROs have been developed to address outcomes associated with a specific
body part or region, a specific disease, or health related quality of life as a whole.
Numerous PROs have been utilized to document patient response to cartilage repair.
While the widespread use of PROs is beneficial for documenting treatment outcomes, the
wide variety in the PROs makes comparison across studies and instruments difficult.
Ideally, a standard instrument or battery of instruments would be more advantageous for
reliably and validly assessing patient response to treatment.
Some of the most commonly used PROs to evaluate articular cartilage repair
outcomes include the Medical Outcomes Study 36-Item Short Form Health Survey (SF36),105, 106, 179 the International Knee Documentation Committee Subjective Knee Form
(IKDC),77 the Lysholm Knee Scale (Lysholm),96, 168 the modified Cincinnati Knee Rating
8

System (MCKRS),31 the Western Ontario and McMaster Universities Osteoarthritis Index
(WOMAC),18, 19 and the Knee Injury and Osteoarthritis Outcome Score (KOOS)148.
While all of these instruments have been widely used to evaluate ACI treatment efficacy,
there is no clear standard regarding which outcome instrument is ideal for evaluating
treatment progress or overall treatment effect following ACI. PRO responsiveness is the
evaluation of change in the instrument score over time in response to treatment.85 The
reported responsiveness in self-reported function following ACI has not been compared
among instruments. Identification of the most responsive instrument for an ACI
population will provide clinicians and researchers with a disease specific tool to compare
treatment effects between therapies.
The purpose of this study is to systematically review and summarize the scientific
literature in regards to changes in PRO scores after ACI treatment. For analysis, we have
selected the commonly utilized outcome instruments in cartilage repair studies including
the IKDC, Lysholm, MCKRS, KOOS, WOMAC, SF-36. The outcome of interest for this
systematic review is PRO responsiveness following ACI treatment. Meta-analyses of
PRO score changes will be compared among instruments to determine the responsiveness
of each instrument at specified postoperative time points. Secondarily, a withininstrument comparison was performed to evaluate the responsiveness of individual PROs
at specified time points to determine if the instrument is more responsive to changes in
self-reported knee function at different time points during recovery. A better
understanding of the responsiveness of each instrument will allow for improved selection
of outcome instruments in future cartilage research.
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Methods
Evidence Acquisition
Search Strategy
In February 2010 investigators conducted a systematic search of the literature
using CINAHL (from 1981), Medline (from 1966), and SPORTDiscus (from 1800) to
identify reports of PROs following autologous chondrocyte implantation/ transplantation.
Search terms used were autologous, chondrocyte, outcome, and knee. All abstracts were
then reviewed for study inclusion/exclusion. In the event the abstract did not provide
sufficient information to determine study eligibility the full manuscript was reviewed.
Additionally the reference lists of all included studies were reviewed to identify other
potentially eligible studies (Figure 1.1.).

Selection Criteria
All studies were required to meet the following inclusion criteria; 1) publication in
the English language, 2) investigations with human participants, 3) prospective evaluation
of patient outcomes following cell based treatment of articular cartilage defects with some
form of cultured autologous chondrocytes, 4) utilization of at least one of the following
PRO instruments: IKDC, Lysholm Knee Scale, MCKRS as described by Browne et al.31,
KOOS, WOMAC, or SF-36 Physical Component Scale (SF-36 PCS) preoperatively and
at a minimum of 1 postoperative time point, and 5) reporting of statistics from which
effect sizes and 95% confidence intervals could be calculated. These included sample
sizes and any of the following: preoperative and postoperative means and standard
deviations, exact p-values for identified parametric statistical tests, preoperative and
postoperative means and standard errors, or mean change scores and standard deviations.
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Figure 1.1 Search Process and Study Selection Results for Patient Reported
Outcomes Following Autologous Chondrocyte Implantation
Searched:
Cumulative Index to Nursing and Allied Health Literature
(CINAHL), Medline, and Sports Discus.
Keywords: autologous, chondrocyte, outcome, and knee

216 studies
identified.

143 studies excluded following
abstract and title review
73 studies included
based on abstract
and title
40 studies excluded due to
insufficient data reporting
33 studies included
after full
manuscript review
9 additional studies identified
from review of reference lists
42 studies
selected for
final inclusion

Assessment of Methodological Quality and Level of Evidence
The quality of all included studies was assessed using the Coleman Methodology
Score modified by Kon-Verdonk.37, 87 This assessment tool was specifically adapted to
evaluate the quality of cartilage repair studies and includes 11 parameters on a 100 point
scale (100 = highest quality): study sample size (10 points possible for >60 defects
evaluated), average follow-up period (10 points possible for a mean follow-up >60
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months), number of concomitant surgical procedures performed (10 points possible if
only a single isolated surgical procedure was reported on), study design (15 points
possible for a randomized controlled trial), description of the surgical procedure (up to 5
points for adequate, detailed description), description of postoperative rehabilitation (up
to 5 points if well described), the inclusion of MRI outcome (10 points possible if results
reported for >80% of patients), the inclusion of histological outcome (10 points possible if
reported for >50% of patients), outcome criteria (5 points if clearly defined with reported
good reliability and sensitivity), procedure for assessing clinical outcomes (up to 7 points
for patient recruitment, investigator independent from surgeon, and independent patient
completion of outcomes), and description of subject selection process (up to 8 points for
clear and unbiased selection criteria and >80% recruitment rate).87
Level of evidence was evaluated based on criteria from the Centre for Evidence
Based Medicine4 and was used to characterize the quality, quantity, and consistency of
the included studies. Using this taxonomy, the quality of the evidence for the included
studies was determined and a grade of recommendation was generated for the use of each
PRO as a measure of ACI treatment effect. Consistent level 1 studies yields a grade of
A.4 A grade of B results from consistent level 2 or 3 studies or extrapolations from level 1
studies.4 A grade of C is given for level 4 studies or extrapolations form level 2 or 3
studies, and a grade of D is the result of level 5 evidence or inconsistent or inconclusive
evidence regardless of the level of evidence.4
Methodological quality assessment and the rating of the level of evidence were
assessed independently by two investigators. Discrepancies in scoring were discussed
until a consensus score was agreed upon.
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Data Extraction
The primary outcome variables of interest were scores on 6 specified PROs: the
IKDC, Lysholm Knee Scale, MCKRS, KOOS, WOMAC, and SF-36 PCS. From each
study all data that could be used for the calculating of effect sizes for PROs was extracted.

Medical Outcomes Study 36-Item Short Form Health Survey Physical Component Score
(SF-36 PCS):
The entire SF-36 is frequently used as a global measure of health-related quality
of life (HRQOL) in all patient populations.64 It is also commonly used as a criterion
reference scale in many studies validating region and disease specific scales.25, 26, 78, 85, 103,
136, 147, 148

Traditional scoring of the SF-36 involves 8 individual sub-scales1 but the SF-36

has also been reported as 2 summary physical and mental scores or as a single score.64
Test-retest reliability for SF-36 PCS has a reported ICC value of 0.92 to 0.95 among
former articular cartilage patients (minimum 5 years post-ACI surgery).58 SF-36 PCS
evaluates physical knee function across a variety of activities ranging from activities of
daily living such as dressing and bathing to general questions about more demanding
activities such as climbing stairs, walking more than a mile or participating in strenuous
sports. However, unlike the IKDC the SF-36 does not address specific joint functions
such as landing, pivoting, or starting and stopping. The SF-36 uses a normative based
scoring system under which 50 represents an average score based on historical data.1

Lysholm Knee Scale (Lysholm):
The Lysholm scale contains 8 items that are scored as a single scale. 96, 168 For
overall score, measures of internal reliability are consistent across authors ranging from
0.65 to 0.73.25, 26, 85, 168 The Lysholm has been documented as having high test-retest
reliability across a variety of knee patients including those undergoing microfracture for
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treatment of articular cartilage defects85 with ICC values ranging from 0.89 to 97.25, 26, 103,
104, 136, 168 85

Specifically, this scale evaluates knee symptoms – locking, stability, pain ,

and swelling – in addition to function during common low to moderate activities
including walking, stair climbing and squatting. Unlike the IKDC, KOOS, or SF-36 PCS
no part of the Lysholm addresses sport participation or knee function during sporting
activities.

Modified Cincinnati Knee Rating System (MCKRS):
The Cincinnati Knee Rating System in its full form has undergone multiple
revisions and been presented in various modified formats since its introduction.124-128
While the original scale is more complex, a modified version of the Cincinnati Knee
Rating System that has been commonly used to evaluate ACI patients consists of one to
three simple questions asking patients to rate their perception of their knee, their pain, and
their swelling on a 0 (severe) to 10 (normal knee/No problems) scale with descriptive
references provided for all even values.31 Because of the variation in Modified Cincinnati
Knee Rating Systems reported in the literature only the MCKRS presented by Browne et
al. was included in this review.31 To avoid inappropriate comparison of various versions
of MCKRS, studies that were included were required to either publish the scale directly in
the manuscript or provide a clear reference for its use. Reliability for a version of the
MCKRS has been evaluated in a population of former ACI patients where an ICC of 0.80
to 0.91 was observed; however, caution should be used in interpreting this value as no
reference was provided for what version of the MCKRS was evaluated.58
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Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC):
The WOMAC is a disease specific instrument evaluating pain, stiffness, and
function typically in an osteoarthritic (OA) patient population.18, 19 This instrument may
be presented in a visual analogue scale format or as Likert type scales. A total score can
be calculated by combining the pain, stiffness, and function subscales. An ideal score is
zero, representing no disability, while the worst possible total score is 96 points (20 points
pain, 8 points stiffness, 68 points function). Test-retest reliability among former ACI
patients for the individual subscales and for the total WOMAC score has been reported to
have ICC values ranging from 0.75 to 0.93.58 While all cartilage repair patients do not
have OA, most experience the joint swelling, crepitus, pain, and loss of function that
typically characterizes OA and which the WOMAC evaluates. This instrument does not
require high level strenuous physical activity to achieve maximum scores. By focusing
on evaluating low to moderate demand activities of daily living (sitting, bathing, rising
from sitting, household chores, etc.), the WOMAC may be an appropriate PRO among
patients who do not desire to return to high level activity.

International Knee Documentation Committee Subjective Knee Form (IKDC):
The IKDC is a 20 item instrument that was developed by reviewing existing
patient report instruments to create a consensus form that could be used to document
changes in HRQOL over time for patients with various knee problems.76 The IKDC is
typically scored as a single scale instrument representing symptoms, activity, and sports
function as a single construct.77 Test-retest reliability has been observed among former
ACI patients (minimum of 5 years post ACI) with ICC values ranging from 0.91 to 0.93.58
Of the scores included in this review the IKDC evaluates the highest level of function
with questions regarding jumping, pivoting, squatting, and stopping and starting quickly.
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Knee Injury and Osteoarthritis Outcome Score (KOOS):
The KOOS consists of 42 questions with 5 item Likert-type response choices
covering the domains of activities of daily living (17 questions), symptoms (7 questions),
pain (9 questions), knee related quality of life (4 questions), and sports and recreation (5
questions).148 The KOOS was originally developed for use with patients with anterior
cruciate ligament injuries, meniscus injuries, or post-traumatic osteoarthritis and contains
all of the questions included in the WOMAC.148 Each subscale is scored out of 100
possible points with 100 representing no knee problems. A total KOOS score is also
occasionally reported out of a possible 100 points. In its initial reliability evaluation
among knee patients ICC values ranged from 0.75 to 0.93 across all subscales.148 The
Dutch version of the KOOS, yielded ICC values of 0.87 to 0.95 for individual subscales
and 0.97 for the overall KOOS among articular cartilage patients.17 The existence of
multiple subscales within the KOOS allows for the evaluation of varying levels of
function from activities of daily living to sports activities within a single outcomes
instrument. While the multiple subscales can be cumbersome to compare across groups,
unlike the IKDC or the Lysholm they allow the identification of treatment effects in
individual domains relating to pain, symptoms, function, and quality of life.

Data Analysis
For each outcome score, individual pre- to postoperative effect sizes were
calculated using bias-corrected Hedge’s g with 95% confidence intervals (CI). Separate
meta-analyses were then performed to provide a summary response for each PRO at
individual specified time points. For the purposes of analysis, follow-up time points were
grouped into 4 categories, Time Point I (less than 1 year); Time Point II (1 year to less
than 2 years); Time Point III (2 years to less than 4 years); and Time Point IV (4 years or
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greater). For each meta-analysis, a random effects model was employed. In comparison
to the fixed effect model, the random effects model provides a more conservative
summary effect by estimating the mean effect size and confidence interval for the
distribution of all relevant true effect sizes.24 We chose this model specifically because
the effect sizes and confidence intervals analyzed in each meta-analysis were generated
from independent studies that utilized similar, but nonuniform methods.24
Individual measures across the multiple studies were pooled from the included
studies using a bias-corrected Hedges’ g24 and 95% confidence intervals to examine the
magnitude and precision of the difference between pre- and postoperative PRO scores.
Most studies made multiple comparisons across separate time points. Each comparison
was treated independently within the statistical analyses of the measurement parameters.
All effect sizes, 95%CIs, and Z-distribution p-values were calculated in Comprehensive
Meta Analysis (Comprehensive Meta Analysis Version 2.0, Biostat, Englewood, NJ). It
is important to note that Hedges’ g is a standardized effect, which creates a unitless
measure which is also corrected to represent an effect that exists on a parametric
distribution. Across the parameters, the standardized effects were pooled for each PRO
using meta-analyses conducted in Comprehensive Meta Analysis. A positive effect size
indicated improvement in postoperative PRO score compared to preoperative score.
Effect sizes for which confidence intervals did not overlap were considered to be
significantly different. To interpret the strength of the effect sizes, Cohen’s guidelines
were used.36 Values were interpreted as small if they were between 0.20 and 0.49,
moderate if between 0.50 and 0.79, and values of more than 0.80 were interpreted as
large.36
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Assessment of Publication Bias
To assess the likelihood of publication bias, a funnel plot of all measures included
in the study was generated by plotting standard error against Hedge’s g effect size for
each included study. To assess the robustness of the observed overall effects of the
variations in study design on PRO score, Orwin’s Fail-Safe N test was employed.132 For
this test a Hedge’s g effect size of 0.1 was assumed for all missing studies, or studies
excluded due to publication bias, and the number of missing studies necessary to reduce
the overall mean effect size for each instrument to a 0.4 was calculated. These values of
were chosen to determine how many studies demonstrating a negligible effect (0.1) would
be needed to be added to the existing sample of studies to result in a small (0.4) overall
mean effect.

Results
Study Selection
The initial literature search yielded 216 results. Application of inclusion and
exclusion critera resulted in the inclusion of 42 articles.14, 16, 23, 27, 31, 41, 42, 44, 48, 50, 54, 55, 65-67,
69, 84, 86, 89, 98, 100, 107, 108, 112, 115, 118, 121-123, 129, 133, 135, 137, 146, 149-152, 158, 171, 185, 186

Study

selection and inclusion is depicted in Figure 1.1. Those studies included in the study are
summarized seen in Table 1.1. A total of 2016 patients with a mean age of approximately
34.5 yrs are reported on in the included studies. Overall, 16 studies reported outcomes
using the IKDC, 11 studies used the KOOS (2 reporting only total KOOS scores), 18
studies reported values for the Lysholm, 12 studies used the MCKRS, 9 studies reported
SF-36 PCS values, and only 2 studies meeting the inclusion criteria utilized the WOMAC.
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Methodology Scoring and Level of Evidence
The mean modified Coleman Methodology Score for all included articles was 50.9
± 9.2, with a range of 35 to 68. Overall, the least reported parameters were of inclusion of
MRI outcomes, inclusion of histological outcomes, and description of subject selection
process. CEBM level of evidence was 2b for 38 articles and 1b for 4 articles included.
Based on the consistent reporting of level 2 studies a grade B recommendation was made
for the use of the IKDC, KOOS, Lysholm, MCKRS, SF-36 PCS, and WOMAC as
outcome measures following ACI.4

Assessment of Publication Bias
A funnel plot of all measures included in the meta-analysis portion of this study
can be seen in Figure 1.2. The funnel plot displays an asymmetrical distribution of
studies with a disproportionate number of studies above the mean effect size at the bottom
of the funnel. These results suggest a slight publication bias towards studies
demonstrating large treatment effects, particularly for studies with smaller sample sizes.
However, the results of the Orwin’s Fail Safe N test (Table 1.2) demonstrate that an
additional 14 (SF-36 PCS) to 196 (KOOS) studies with a trivial effect size of 0.10 are
necessary to reduce the mean effect size for any of the PROs to a weak value of 0.40,
meaning that the observed overall effects are very robust and not likely to be artificially
influenced by this potential publication bias.
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Basad et al. 201014
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ACI-P with or without
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ACI-P
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ACI-P Patellofemoral with
or without realignment

MACI Patellofemoral

ACI-P c/Meniscus
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ACI-P
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MACI
MACI
ACI-C w/Meniscus
Allograft Transplant
ACI-C

Procedure Included*

5
0.5,1,4
4.91

.5,1,2
1,2

3.52

1,2

2,6.29
.75,1,2

2

4.5

0.5,1
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1, 5

5
3
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M
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I

L

L
L
L
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40

20
39

170

53

34
44

32

29

13

62

65

87
25

14

39
33
8

Total N
analyzed

MFC, LFC, Troc
MFC, LFC, Pat
Troc

MFC, LFC, Troc,
Pat
MFC, LFC, Troc,
Pat
MFC, LFC, PFJ
MFC, LFC

Pat, Troc
FC, Troc, Pat

Pat, Troc

MFC, LFC, Troc,
Pat
MFC, LFC,
Kissing

MFC, LFC

MFC, LFC, Troc

FC, Troc, Pat
MFC, LFC, Pat
MFC, LFC,
Kissing
MFC, LFC, Troc,
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MFC, LFC, Troc
MFC, LFC

Lesion
Locations‡

2.2
4
4.5

3.86
5.1

3.45

3.7

4.45
3.07
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5.35, troc 4.77,
other 2.68
4.7
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3.3

2.25

4.9
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2b
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Level of
Evidence4
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40
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50
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Coleman
Methodology
Score§87
45
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ACI-P
MACI

ACI-P
ACI-P Patellofemoral

ACI-P

MACI
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Marcacci et al. 2005100

Study

2

2,3
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.5,1,2

4

.5,1,2

2

0.5,1
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4.3
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L
K
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L
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56
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27

52
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4.7
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1- 10 (range)

4.2

4.6

2.93

4.3
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5.4
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3.5
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2b
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Level of
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39
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45
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52
39
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Methodology
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Figure 1.2. Funnel Plot to Evaluate Publication Bias
Funnel Plot of Standard Error by Hedges's g
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Figure 1.2 The observed funnel plot suggests a slight publication bias towards studies
demonstrating larger effect sizes, with an asymmetrical distribution of studies at the
bottom of the funnel.

Table 1.2. Orwin's Fail Safe N Analysis to Evaluate Publication Bias
Instrument

*

N

†

IKDC

95

Lysholm

83

KOOS

196

MCKRS

48

SF-36 PCS

14

Overall Across All Instruments

399

*IKDC: International Knee Documentation Committee Subjective Knee Form, Lysholm:
Lysholm Knee Scale, KOOS: Knee Injury and Osteoarthritis Outcome Score. MCKRS:
modified Cincinnati Knee Rating System: SF-36 PCS: Medical Outcomes Study 36-Item
Short Form Health Survey Physical Component Scale
†Number of studies with an effect size of 0.1 needed to reduce the overall mean effect
size to 0.4
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Responsiveness of PROs
Mean effect sizes and 95% confidence intervals (CIs) for each instrument at each
of the four time points are reported in the Forrest plot in Figure1.3 and Figure 1.4. For an
instrument to be included in the meta-analysis at a given time point a minimum of 4
individual data points must have been reported. The WOMAC did not meet this
requirement at any time point, and the SF-36 PCS only met this requirement at time point
III. The MCKRS could only be evaluated at time points III and IV and only the patient
perception scale could be evaluated.

Responsiveness within Instruments Across Time Points
For all evaluated instruments none of the mean effect sizes or confidence intervals
encompassed zero, indicating that there is evidence of positive treatment effects following
ACI regardless of the PRO utilized (Figures 1.3). The IKDC was observed to have
increasing responsiveness over time, as measured by Hedge’s g effect sizes, with time
point IV demonstrating a significantly greater mean effect size (mean effect size [95
CI%]: 1.78 [1.33, 2.24] than time point 1 (0.88, [0.69, 1.07]). The responsiveness of the
Lysholm varied little across time points with mean effect sizes only ranging from 1.29 to
1.69. There was also no difference in responsiveness for the MCKRS between time points
II and III. Finally, the only KOOS subscale to show improvements in responsiveness
over time was the KOOS-sports and recreation subscale for which time point III (1.76
[0.87, 2.64] and time point IV (0.98 [0.81, 1.15] were significantly more responsive than
time point I (0.61 [0.44, 0.78]).
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Figure 1.3. Forrest Plot of Effect Sizes by Patient Reported Outcome Among
Autologous Chondrocyte Implantation Patients
Key:

Time I (0 to <1 year) Time II (1 to < 2 years)
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Time II 14, 16, 27, 69, 84, 121, 122, 129,
Time III 50, 107, 115, 135, 137
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Time IV
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150, 171, 186
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instrument by time point. IKDC: International Knee Documentation Committee
Subjective Knee Form, Lysholm: Lysholm Knee Scale, KOOS-ADL: Knee Injury and
Osteoarthritis Outcome Score Activities of Daily Living subscale, KOOS-pain: Knee
Injury and Osteoarthritis Outcome Score Pain subscale, KOOS-QOL: Knee Injury and
Osteoarthritis Outcome Score Quality of Life subscale, KOOS-Sports: Knee Injury and
Osteoarthritis Outcome Score Sports and Recreation subscale, KOOS-Symptoms: Knee
Injury and Osteoarthritis Outcome Score Symptom subscale. MCKRS Patient: modified
Cincinnati Knee Rating System Patient Perspective: SF-36 PCS: Medical Outcomes
Study 36-Item Short Form Health Survey Physical Component Scale.
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Figure 1.4. Forrest Plot of Effect Sizes by Time Point Among Autologous
Chondrocyte Implantation Patients
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Lysholm 133, 146, 150, 185
KOOS-ADL 133, 146, 150, 185
KOOS-Pain 133, 146, 150, 185
KOOS-QOL 133, 146, 150, 185
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133, 146, 150, 185
KOOS-Symptoms
66, 67, 121, 149, 185
MCKRS 66, 67, 84, 149
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IKDC 50, 107, 115, 135, 137
Lysholm 89, 107, 135, 185
KOOS-ADL 89, 107, 135, 185
KOOS-Pain 89, 107, 135, 185
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KOOS-Sports
89, 107, 135, 185
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31, 50, 98, 108, 112, 118, 185
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Figure 1.4. Random effects model summary mean effect sizes for each patient reported
outcome instrument at each time point. IKDC: International Knee Documentation
Committee Subjective Knee Form, Lysholm: Lysholm Knee Scale, KOOS-ADL: Knee
Injury and Osteoarthritis Outcome Score Activities of Daily Living subscale, KOOS-pain:
Knee Injury and Osteoarthritis Outcome Score Pain subscale, KOOS-QOL: Knee Injury
and Osteoarthritis Outcome Score Quality of Life subscale, KOOS-Sports: Knee Injury
and Osteoarthritis Outcome Score Sports and Recreation subscale, KOOS-Symptoms:
Knee Injury and Osteoarthritis Outcome Score Symptom subscale. MCKRS Patient:
modified Cincinnati Knee Rating System Patient Perspective: SF-36 PCS: Medical
Outcomes Study 36-Item Short Form Health Survey Physical Component Scale.
Responsiveness by Time Point
At time point I the Lysholm (1.52 [0.92, 2.11]) was significantly more responsive
than the KOOS-sports and recreation subscale (0.61 [0.44, 0.78]) (Figure 1.4). At time
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point II both the IKDC (1.37 [0.93, 1.80]) and the Lysholm (1.53 [0.96, 2.11]) were
significantly more responsive than the KOOS-sports and recreation subscale (0.57 [.23,
.92]). There were no significant differences between any of the instruments at time point
III. Finally, at time point IV the IKDC (1.78, [1.33, 2.24]) was significantly more
responsive than the KOOS-sports and recreation subscale (0.98 [.81, 1.15]).

Overall Responsiveness
The final comparison was of the overall responsiveness of each instrument with
data from all available time points combined (Figure 1.5). This analysis demonstrated
that overall the SF-36 PCS (0.60 [0.46, 0.74]) was significantly less responsive than all
other instruments and subscales with the exception of the KOOS-sports and recreation
subscale (0.87 [0.68, 1.07]). Both the Lysholm (1.52 [1.25, 1.80]) and the IKDC (1.34
[1.14, 1.54]) had overall mean effect sizes that were significantly greater than the overall
mean effect size for the KOOS-sports and recreation subscale. With all time points
combined the Lysholm was also significantly more responsive than the KOOS-symptoms
subscale (1.01 [0.83, 1.19]).

Discussion
The primary purpose of this study was to evaluate the responsiveness of common
PROs to the treatment effects of ACI. An underlying assumption of this review was that
ACI would have a common effect across studies and varying ACI procedures. While
evaluating ACI efficacy was not a purpose of this review, the results of this systematic
review and meta-analyses are in agreement with previous reviews documenting ACI to be
a viable procedure resulting in positive patient outcomes.62, 87, 176 A strength of our
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Figure 1.5. Forrest Plot of Summary Mean Effects Sizes Across all Time Points for
Each Patient Reported Outcome
42, 54, 55, 65-67, 86, 89, 100, 107, 121-123, 135,
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Effect Size

44, 89, 107, 133, 135, 146, 150, 152, 185

31, 48, 50, 66, 67, 98, 108, 112, 118, 121, 149, 185

44, 66, 67, 84, 112, 149

1

2

Random effects model summary mean effect sizes for each patient reported outcome
instrument across all time points combined. IKDC: International Knee Documentation
Committee Subjective Knee Form, Lysholm: Lysholm Knee Scale, KOOS-ADL: Knee
Injury and Osteoarthritis Outcome Score Activities of Daily Living subscale, KOOS-pain:
Knee Injury and Osteoarthritis Outcome Score Pain subscale, KOOS-QOL: Knee Injury
and Osteoarthritis Outcome Score Quality of Life subscale, KOOS-Sports: Knee Injury
and Osteoarthritis Outcome Score Sports and Recreation subscale, KOOS-Symptoms:
Knee Injury and Osteoarthritis Outcome Score Symptom subscale. MCKRS Patient:
modified Cincinnati Knee Rating System Patient Perspective: SF-36 PCS: Medical
Outcomes Study 36-Item Short Form Health Survey Physical Component Scale

review is that we included a more comprehensive review of the available literature.
Previous systematic reviews have limited study inclusion to evaluation of randomized
controlled trials,176 comparisons to other cartilage treatments,62 or studies of the third
generation MACI version of ACI.87 In previous reviews, the maximum number of
included studies was 1887 while the present investigation included 42 studies. Current
inclusion criteria captured a wider variety of patients and defect locations representing all
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surfaces of the tibiofemoral and patellofermoal joints. The large mean effect sizes and
narrow confidence intervals observed in this review support the use of ACI for the
generalized treatment of articular cartilage defects.

Responsiveness
The results of this review demonstrate that regardless of the duration of postoperative follow-up all instruments were responsive to patient improvement following
ACI; however, the IKDC and Lysholm may be more responsive than the MCKRS,
KOOS, or SF-36 PCS. There was insufficient data to adequately evaluate the WOMAC.

Responsiveness Within Patient Reported Outcome Instruments Across Time Points
The Lysholm demonstrated large mean effect sizes (1.30 to 1.70) with little
variation across the four examined time points (Figure 1.2). The observed confidence
intervals for the Lysholm at all four time points overlap by more than 50% suggesting
little changes in responsiveness as time since ACI progresses. Common rehabilitation
recommendations following ACI restrict return to sports participation for 12 to 18 months
following surgery. 9, 53, 61 This delayed return to physical activity may result in lower
scores on instruments that emphasize higher demand sports activity. Because the
Lysholm primarily assess every day activities (walking, squatting, stair-climbing) and
does not address sports activity, delayed return to higher level physical activity has little
influence on Lysholm score. The lower demand activities evaluated in the Lysholm are
functional goals addressed early in rehabilitation, and patients may see little improvement
in these activities beyond the 1 year time point. The result is a potential ceiling effect for
Lysholm scores which may explain its limited changes in responsiveness over time (i.e.
confidence intervals overlap for all 4 time points). Therefore, the Lysholm scale may be
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ideal for evaluating short-term outcomes or outcomes among patients not intending to
return to sports, but it is less responsive to changes seen during long-term recovery as
individuals return to higher demand activities.
The IKDC also demonstrated large effect sizes. However, a significant increase in
mean effect size was observed between time point I and time point IV with mean effect
size increasing from 0.88 to 1.78 with no overlap between confidence intervals. This
difference demonstrates increased treatment effects over time when evaluating outcomes
with the IKDC. Greco et al. observed a similar trend with responsiveness of the IKDC
increasing between 6 and 12 months in a cohort of surgical cartilage patients.58 It has
previously been reported that functional and structural improvements following cartilage
repair continue beyond 1 year postoperatively.22, 90, 145 The observed increases in mean
effect size over time may represent the IKDC’s responsiveness to continual improvements
in function that occur in the years following ACI surgery. The responsiveness of the
IKDC to continued improvements over time can be considered a strength of this
instrument and may be due to its inclusion of sporting activities. A wide variety of
function can be documented with the IKDC, ranging from the inability to participate in
any activity without symptoms to full participation in strenuous activities such as jumping
or pivoting. The IKDC allows for continued improvement as individuals initiate return to
strenuous activity and sports participation beyond the one year postoperative time point.
The KOOS-sports and recreation subscale had the lowest mean effect at time
points I and II while the KOOS-symptoms subscale had the lowest mean effect of all the
KOOS scales at time points III and IV. Responsiveness as evaluated by the mean effect
size for the KOOS-sports and recreation subscales was significantly lower at time point I
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compared to time points III and IV. These results are similar to that which was observed
with the IKDC, and this progressive improvement in responsiveness over time may be
related to the slow, progressive return to sports following ACI. For all other KOOS
subscales no significant changes were seen for mean effect size between time points with
all confidence intervals overlapping. Overall the KOOS was responsive to changes
following ACI; however, the KOOs-sports and recreation subscale was the only subscale
to demonstrate increasing mean effect sizes over time, suggesting that it responded to
increasing treatment effects as healing progressed.
The MCKRS contains the fewest questions of the instruments included in this
review, consisting of one to three questions. Only the single item of the MCKRS had
sufficient data for inclusion in the meta-analyses. There was only sufficient data to
evaluate the MCKRS at time point III and time point IV, limiting any conclusions that can
be drawn regarding the changes in its responsiveness over time. Although the results of
this review suggest that the MCKRS is responsive to changes in patient function
following ACI, caution is urged regarding the use of this instrument. Many different
versions of the MCKRS exist and many authors fail to reference the version of MCKRS
they use. Similarly, appropriate psychometric properties for the MCKRS have rarely
been reported. This made selection of appropriate studies difficult, for example, several
articles were excluded at least in part because the authors did not reference the version of
the MCKRS utilized, or because a different version than the one presented by Browne et
al.31 was utilized as an outcome measure.7, 13, 20, 21, 57, 80, 90-92, 164 Due to ambiguity
regarding the use of “modified” Cincinnati Knee Rating Systems the developers of the
original Cincinnati Knee Rating Scale discourage the use of any modified versions.11

31

However, because of the frequency with which the Browne et al.31 version of the MCKRS
has been clearly referenced in the ACI outcomes study it was chosen for inclusion in this
review.
Both the SF-36 PCS and the WOMAC had limited data available for analysis. For
the SF-36 PCS there was only sufficient data for analysis of responsiveness at time point
III. For this time point the SF-36 PCS did demonstrate a positive mean effect 2 to 4 years
following ACI treatment with an effects size of 0.92[0.55,1.28]. There was insufficient
data to include the WOMAC in any of the meta-analyses performed. Only two studies
were available that utilized the WOMAC and reported sufficient data for calculating
effect sizes, and even these studies failed to report results for all three WOMAC
subscales.112, 149 While additional studies have included the WOMAC as an outcome
measure the results were only reported using non-parametric statistics and/or without the
reporting of means and standard deviations, or other data necessary for calculating effect
sizes.110, 111, 113, 114 As a result no clear conclusions regarding the responsiveness of the
WOMAC as an outcome instrument can be reached based on this review.

Responsiveness between Patient Reported Outcome Instruments
The Forrest plots of PRO instruments by time point can be seen in Figure1.4,
while the overall mean effect sizes across all time points can be seen in Figure 1.5. The
IKDC and the KOOS- sports and recreation subscales were the only instruments to
demonstrate significant changes in responsiveness over time. These changes may be
related to activity restriction and gradual return to sports following ACI. The restrictions
on sporting activity during the first year post-ACI may also explain the significant
differences observed between the responsiveness of the KOOS-sports and recreation
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subscale and the Lysholm at time points I and II (Figure 1.4). At time point II and time
point IV the IKDC was more responsive than the KOOS-sports and recreation subscale.
These differences may be the result of the wider range of physical functioning addressed
in the IKDC as compared to the KOOS-sports and recreation subscale. At both time point
III and time point IV the confidence interval surrounding the mean effect size for the
MCKRS overlapped with the confidence interval for all other instruments, indicating that
the responsiveness of the MCKRS was not significantly different from any other
instrument evaluated. Overall and at time point III the SF-36 PCS had the lowest
responsiveness as measured by mean effect size. This finding is not surprising given that
the SF-36 is the only included instrument not designed specifically for the evaluation of
knee function. The SF-36 may be more useful when evaluating HRQOL; while the
IKDC, Lysholm, MCKRS, and all KOOS subscales, with the exception of the sports and
recreation subscale, are more responsive than the SF-36 PCS to changes in knee function
following ACI.
Examination of overall responsiveness without regard to individual time points
demonstrates that the Lysholm and IKDC were observed to have the largest mean effect
sizes with significantly greater responsiveness than the KOOS-sports and recreation
subscale and the SF-36 PCS (Figure 1.5). While both the KOOS and IKDC include
sports participation as components of evaluating knee function, the IKDC is significantly
more responsive to overall changes in function following ACI (Figure 1.5). This overall
difference, combined with the significant differences in responsiveness between the
IKDC and KOOS-sports and recreation subscales at time points II and IV leads us to
propose that the IKDC may be the preferred outcome instrument for evaluating long-term
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outcomes following ACI, particularly among patients whose goals include return to
sporting activity. Although all KOOS subscales are responsive to treatment effects
following ACI, the IKDC and Lysholm are shorter instruments with single score
outcomes and overall are more responsive to change than some subscales included in the
KOOS. Based on these observations, the IKDC and the Lysholm may be preferable to the
KOOS for documenting treatment effects following ACI.

Study Quality
The mean modified Coleman Methodology score (50.9 + 9.2) among studies
included in this review was comparable to other recent reviews of ACI and other cartilage
repair procedures. Harris et al. reported a mean modified Coleman Methodology score of
54 in 13 studies comparing ACI to other cartilage repair treatments.62 Evaluation of
MACI procedures resulted in observed scores of 53.1 + 1.5.86 In a general review of
cartilage repair procedures using a different variation of the Coleman Methodology Score,
Jakobsen et al. reported a mean score of 43.51 + 12.1.81 The slightly lower methodology
score observed in our review compared to those by Harris et al.62 and Kon et al.87 is not
surprising given the broad inclusion criteria for this review which did not seek to compare
different cartilage repair techniques or different generations of ACI. Also, the present
review included several studies that are over 5 years old and a general trend towards
increasing study quality over time has been previously reported.62 Regardless of the
selection criteria utilized, this review and others demonstrate the need for improved
research methodology and reporting of outcomes in future cartilage repair investigations
While the modified Coleman Methodology Score reported in this review provides
a set of standardized criteria by which to evaluate cartilage research, it is not without
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limitations. The scale is heavily weighted towards diagnostic, clinician based outcomes
with up to 20 points of the 100 point score dependent on MRI and histological evaluation.
The relationship between MRI and clinical outcome is not definitive with some authors
observing low to moderate correlations between MRIs and PROs, 34, 101, 146 and others
failing to observe such a relationship.167, 175 Similarly, histological analysis can involve a
wide variety of techniques and may not be ethical in cases where reoperation is not
otherwise indicated. Of the 42 studies included in our review only a single study158
received full credit for both histological and MRI outcomes, suggesting that the
requirement of these outcomes may not be applicable in a clinical research setting.
Other areas where the included studies received less than 50% of the possible
methodology points available on average were the reporting of recruitment rate
(documented in only 2 studies149, 185), investigator independence, duration of follow-up,
and number of different surgical procedures included. Only 8 studies clearly stated that
the investigator documenting outcomes did so independently from the operating
surgeon.27, 31, 84, 98, 112, 149, 152, 158 To receive the full 10 points allotted for duration of study
follow-up, outcomes beyond 60 months were required to be reported, a requirement that
was only met by 5 studies.31, 54, 86, 118, 137 Finally, only 5 studies scored a full 10 points for
> 90% of subjects undergoing one surgical procedure with less than 10% undergoing
concomitant procedures.16, 69, 84, 150, 158 It is important to note that while common
concomitant procedures such as osteotomies, meniscal allograft transplants, or ligament
reconstructions reduced the overall methodological score, studies that included these
procedures are much more generalizable to real clinical practice than studies of single
isolated defects.46
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Limitations
The results of this review are limited by the quality and strength of the studies and
PROs selected for inclusion. As evidenced by the low modified Coleman Methodology
Score observed in this review and others, the quality of reporting in cartilage outcomes
studies is variable and generally poor. Similarly, the included studies presented an
expansive range of patients of various ages, with chondral defects of varying size and
location, and who underwent an assortment of concomitant procedures. A random effects
analysis was utilized to account for the variability between studies allowing our results to
be generalized to a broad clinical population.
Numerous other PROs could have been selected for inclusion in this review;
however, only the IKDC, Lysholm, MCKRS, KOOS, SF-36 PCS, and WOMAC were
selected for review. As a result the conclusions drawn from this study can only be
applied relative to these PROs. These PROs were chosen based on the interest of the
authors, their established psychometric properties, and the frequency of their use within
the articular cartilage literature.
Finally, a statistical limitation of our study is the use of multiple measures at
multiple time points from within the same study populations. For studies with multiple
outcome measures (Example: both IKDC and MCKRS) all evaluated outcome scores
(Example: 1 year and 3 years) were included as independent measures. We acknowledge
that outcome scores obtained from within the same sample are likely correlated, but given
that the correlation between outcome measures and time points is rarely reported,
correction for this relationship was not feasible. Fortunately, the observed mean effect
sizes are so large and the confidence intervals so small for the included outcome
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instruments that we do not believe this assumption violation significantly influences the
overall conclusions of this review.

Conclusions
Evidence for the use of ACI as a treatment for chondral defects consists primarily
of level 2b observational cohort studies. The methodological quality of many of these
studies is limited by the absence of diagnostic outcomes such as MRI and histological
analyses, small sample size, short-follow-up, and high frequency of concomitant
procedures. In addition documentation of recruitment rate and investigator independence
was lacking from many studies. The IKDC, Lysholm, KOOS, MCKRS, and SF-36 PCS
were all responsive to improvements in function following ACI. A positive treatment
effect for ACI was observed using all instruments with follow-up time points ranging
from less than one year to beyond 4 years. The Lysholm and the IKDC were the most
responsive instruments across time points. The Lysholm was highly responsive as early
as less-than 1 year following ACI and was consistently responsive throughout
postoperative follow-up. However, this instrument may not be responsive to changes in
function associated with the resumption of higher demand activities such as sports which
occurs after the one year time point. For the evaluation of long-term outcomes among
patients with an intent to return to physical activity, this review supports the use of the
IKDC which was able to detect increasing treatment effects overtime. The use of the
Lysholm and IKDC together represents a responsive combination of PRO instruments
that are able to efficiently document both short term and long-term treatment effects
among patients of a variety of activity levels following ACI.
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CHAPTER 2: RELIABILITY OF FORCE PLATE BASED PERFORMANCE
MEASURES FOR EVALUATION OF PATIENTS RECEIVING TREATMENT FOR
KNEE ARTICULAR CARTILAGE DEFECTS

INTRODUCTION
With any form of medical treatment the ability to accurately and objectively
document outcomes is of the utmost importance. This is particularly true in areas with
new and emerging therapies such as the treatment of articular cartilage defects. Within
this rapidly evolving field a variety of different outcomes can be used to evaluate
treatment success. The types of outcomes collected can be classified as disease oriented,
patient oriented, or performance based outcomes. Disease oriented outcomes are those
that are of primary interest to the clinician. Disease oriented outcomes include elements
such as Magnetic Resonance Imaging, graft biopsy, range of motion, or swelling. Patient
oriented outcomes emphasize health related quality of life and focus on the ability to
return to work, social, and recreational activities, and are commonly collected using
patient reported outcome instruments (PROs) such as pen and paper questionnaires.
Finally, performance based outcomes/assessments (PBAs) focus primarily on activities or
functional tasks such as squatting, walking, hopping, or performing a standardized series
of movements that can be objectively quantified by a measurement of kinematic or kinetic
variables (e.g. distance, time, pressure, force, repetitions). All three types of outcomes are
relevant in determining the successfulness of treatment and should be included in any
comprehensive outcomes study. Regardless of the type of outcome being considered it is
imperative that the method being used to measure it is reliable.
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In the existing literature the predominant outcome measure for articular cartilage
treatment via autologous chondrocyte implantation (ACI) has been patient oriented
outcomes documented using PROs.21, 29, 31, 44, 49, 51, 86, 90, 98, 108, 115, 116, 149, 185 Common PRO
instruments including the Lysholm scale 85, International Knee Documentation
Committee Subjective Knee Form58, modified Cincinnati Knee Rating System58, Knee
Osteoarthritis Outcomes Score17, and Western Ontario and McMaster Universities
Osteoarthritis Index58, 147 have been evaluated for reliability among cartilage patients.
One common form of disease oriented outcome evaluation is grading of the
articular cartilage from direct visualization during a second look or follow-up
arthroscopy. The reliability of multiple visual inspection scales have been evaluated
among articular cartilage and specifically ACI patients.161, 174 In general, observational
evaluation of articular cartilage via arthroscopy has acceptable intrarater reliability (ICC =
0.65174 to 0.94161), but interrater reliability and agreement may be highly variable and
specific to each individual group of raters(ICC = 0.5232 to 0.83161). 32, 102, 161, 174 These
disease oriented outcomes are one of the few outcomes that have been specifically applied
to an ACI patient population. However, they are also the least practical outcome measure
to universally collect on ACI patients. In medical practice a second look arthroscopy
cannot ethically be performed routinely. These follow-up surgeries will only be
performed in patients who report dissatisfaction with treatment outcomes or new injury,
resulting in a biased sample. Research is ongoing into less invasive assessment techniques
such as magnetic resonance imaging to reliably document cartilage healing and
structure.83, 95, 140 While these techniques may provide a quality evaluation of tissue
structure and healing, they are not cost effective across large populations, and physical
structure may not always relate to pain and function levels.
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Performance based testing, particularly of the lower extremity, has been suggested
as part of a comprehensive rehabilitation program for several years.12, 63 However, there
are few clear cut recommendations as to what form lower extremity PBAs should take.
The ultimate goal of performance based testing is to asses function by recreating forces
similar to those the body experiences during normal activity or participation.94 This form
of outcomes assessment is relatively new within the ACI literature and is only known to
have been reported in three outcome studies thus far.44, 146, 172 In these studies the 6 minute
walk test44, 47, 146 and a series of single limb hopping tasks172 were the assessments
evaluated. The reliability for these tests or any other PBA has not been established among
patients undergoing articular cartilage repair of the knee.
PBA measures should at minimum have the potential to be evaluated preoperatively and at long-term (e.g. ≥1 year) follow-up. Ideally a measure will also be
suitable for repeated testing throughout the recovery process. The NeuroCom Balance
Master® and long force plate(LFP) (NeuroCom International, Clackamas, OR) together
are a commercially available system designed both as a training and evaluation tool for
functional and balance tasks.5 This system has the ability to provide immediate feedback
to clinicians and patients regarding quality of task performance for a variety of activities
of daily living (ADLs). Additionally, performance values are saved in individual patient
files for easy comparison to evaluate progress over time. Tasks that are part of the LFP
testing protocol that simulate ADLs and have potential as ACI outcome measures include
the unilateral stance, weight bearing squat, sit-to-stand, rhythmic weight shift, step-up and
over, and the forward lunge. These outcome measures are of low to moderate demand
and should be feasible for performance by ACI patients throughout much of the recovery
process. However, for these tasks to be useful as assessments, they must be reliable
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across time points to document changes in function following surgical treatment.
Therefore, the purpose of this study was to evaluate the reliability of a series of force
plate based PBAs among ACI patients.

METHODS
Participants
Twenty-one patients (12 males, 9 females, age 36.4 ± 6.8 years, weight 93.8 ±
21.1 kg, height 175.9 ± 12.1 cm) being treated for articular cartilage defects to the knee
participated in this study. Prior to study enrollment all patients provided institutional
review board approved informed consent. This was a repeated measures study design with
subjects tested 2 times within the same data collection period to evaluate test-retest
reliability. To assess the reliability of measures at various stages of treatment, patients
were either enrolled at their preoperative appointment prior to undergoing ACI (n=9) or at
their 1 year follow-up appointment following ACI (n=12). Nine participants (4
preoperative) were undergoing treatment for defects to the tibiofemoral joint, while 12
participants (5 preoperative) underwent treatment to the patellofemoral joint that included
tibial tubercle transfer in addition to ACI.

Performance Based Assessments (PBAs):
Each participant completed a series of seven functional tasks performed on the
LFP.5 The LFP consists of a 45.72 cm x 152.40 cm force plate with data sampled at 100
Hz and a personal computer equipped with data capture software (Balance Master ver.
8.1). These functional tasks were selected because of their direct relationship to activities
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of daily living and the feasibility of patients being able to complete the task at each testing
time point (Table 2.1). Tests were completed for both testing sessions in the order
presented in Table 2.1, which was determined to be from least to most demanding based
on patient reporting of difficulty during pilot testing. All testing was administered by the
same investigator (JSH). For all single limb tests the uninvolved limb was tested first.
Three successful trials of each task were performed, except for the Weight Bearing Squat
which consisted of a single trial at each joint angle and the Rhythmic Weight Shift which
consisted of one trial at each speed in each direction. Approximately 15s of rest was
provided between each trial and 30s of rest between each task. Following a minimum of
a 15 minute rest period all tests were repeated on the same day. Before, and after each
testing session participants were asked to verbally rate their knee pain on a 0-10 scale.
Changes of more than 2 points between the start of testing sessions were considered to
represent a meaningful change in pain and these participants were excluded from the
reliability analysis. All outcome variables are identified using the names assigned to them
by the software used, and are defined in Table 2.1. The seven tasks are described below.
Walk Across: Patients walked across the LFP using their freely chosen standard gait speed
and pattern.
Weight Bearing Squat: Patients stood still on the force plate at the initial measure was
recorded with knee flexion angles of 0˚, 30˚, 60˚, and 90˚as tolerated 0˚). They then
flexed their knees and held positions at 30˚, 60˚, and 90˚as tolerated. The percentage of
body weight on the involved limb was measured during a single trial with a duration .01s
for each position. A standard goniometer was used to verify joint angle at each position.
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Table 2.1 Functional tasks evaluated on the NeuroCom Balance Master ® Long
Force Plate. All tasks were performed in the order presented by patients treated for
articular cartilage defects to the knee.
Task
Walk
Across

Parameter
NeuroCom Outcome
Assessed
Variable
Characterization of Stride Length (cm)
Gait
Stride Width (cm)

Weight
Proprioception,
Bearing Strength
Squat
Unilateral Balance
Stance
Sit To
Stand

Strength and
Double Limb
Balance

Rhythmic Postural Control
Weight
Shift

Stepup/Over

Concentric
Strength and
Eccentric Control

Definition
Distance between contralateral heel strikes

Lateral distance between center of pressure of left
and right foot strikes
Walking Speed (cm/s)
Speed of forward progression of the center of
gravity (COG)
% Body Weight (BW) at 0° % BW on the involved limb at each position (test
(full extension), 30°, 60°, duration .01s)
and 90° of knee flexion
Center of Gravity (COG) Angular displacement (angle between the center of
Sway Velocity (deg/s)
pressure to theoretical COG vector and horizontal
vector) divided by the 10s duration of the trial
Weight Transfer time (s) Time required from start of motion while sitting (i.e.
increase in center of pressure(COP) forward
velocity by 5% from resting velocity) to achieve full
weight bearing standing (i.e. forward velocity drops
to within 5% of standing resting velocity)
Rising Index (%BW)
Peak vertical force exerted through the legs when
rising to full standing relative to stationary vertical
standing force
COG Sway Velocity
Angular displacement (angle between the center of
(deg/s)
pressure to theoretical COG vector and horizontal
vector) divided by the time to rise and the first 5s
following rising
Weight Symmetry
% Difference in weight supported by each limb
during the weight transfer phase
On-Axis Velocity (deg/s) Average speed of movement in the target direction

Directional Control (ratio) Ratio of movement in the intended direction to
extraneous movement away from the intended
direction
Lift-up Index (%BW)
Peak vertical force occurring while stepping up
onto the box as a percentage of body weight
Impact Index (%BW)

Peak vertical force occurring while stepping down
off the box as a percentage of body weight
Time between initial weight shift (i.e. change in
COP velocity by 5%) and contact with force plate
on opposite side of box (determined by COP
velocity dropping to within 5% of post-test resting
velocity)
Length of lunge step as a percentage of subject
height

Movement Time (s)

Lunge

Concentric and
Distance (% subject
Eccentric Control, height)
Functional Range
of Motion
Movement Time (s)

Duration of lunge phase during which lead leg is in
contact with the force plate. Start and stop of a trial
is determined by 5% change in COP velocity from
pre-test and post-test resting velocity.
Peak vertical force occurring during lunge
maneuver as a percentage of body weight

Impact Index (%BW)
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Unilateral Stance: Patients stood on each leg and maintained their balance for 10 s with
their eyes open. They begin with the non-weight bearing leg flexed at about 60-80˚ and
with their hands on their hips. If patients touched down, or their legs touched each other,
testing was stopped and the trial was discarded. Testing of a condition was discontinued if
a participant experienced three consecutive failed trials. Testing was repeated for both
legs with the patients’ eyes closed.
Sit to Stand: Patients were seated on a 50cm box. Upon both visual and audio signal from
the computer they rose to full standing as quickly as possible without using their hands,
and then maintained a steady stance for the remainder of the 10 s trial.
Rhythmic Weight Shift: Patients stood on the force plate and shifted their center of gravity
(COG) rhythmically left to right or front to back between targets at 1s, 2s, and 3s
intervals. Both visual and audio cues were provided for pacing, as was visual feedback
for the position of the COG. One trial consisted of three complete cycles between targets.
One trial was completed at each speed/direction combination.
Step-Up/Over: Participants stood behind a 29cm high box and stepped up onto the box
with their test leg, then brought their non-test leg up and over the box, and then stepped
down with their test leg. This was performed as quickly as possible while still maintaining
control.
Forward Lunge: Patients in a standing position stepped forward on one leg and squatted
down as far as comfortably possible, and then returned to the initial standing position as
quickly as possible.
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Statistical Analysis
Outcome variables were averaged for the three trials on the involved limb for each
task, except for the Weight Bearing Squat and the Rhythmic Weight Shift. For the
Weight Bearing Squat a single trial at each joint angle was examined. For the Rhythmic
Weight Shift on axis velocity and directional control were averaged across speeds for
each direction (right-to-left and front-to-back) to provide a composite score for each
variable in each direction. The descriptive statistics of minimum, maximum, mean and
standard deviation (SD) were used to summarize the data. Intraclass correlations
(ICC(2,1)) were used to evaluate the test re-test reliability of each outcome measure. For
unilateral tests, only the reliability of the involved (surgical) limb was analyzed. All tests
with ICC greater than or equal to 0.75 were considered to have acceptable reliability as a
PBA for documenting outcomes following ACI. Standard error of measurement
(SEM=SD(√(1-ICC)) values were also calculated to provide a clinical context to the data
by reporting the response stability in the actual units of measures.138 The SEM represents
the range of scores that can be expected on re-testing. PASW 18.0 (SPSS Inc., Chicago,
IL) was used for all statistical analyses.

RESULTS
All Patients
The resulting descriptive and reliability statistics are reported in Table 2.2. No
patients were excluded from the analysis due to changes in self-reported pain between
testing sessions. ICC values when all patients were analyzed as one group ranged from
0.38 to 0.94. For the Walk Across, both stride length and speed demonstrated acceptable
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46

Variable*

28
23
20

30°

60°

90°

Impact (% BW)

Time (s)

Lift-up Index (% BW≥100%)
19

1.14

24

74

Step Up/Over

81

Directional Control FrontBack Composite (%)

61

2.48

65

88

94

6.20

2.90

Directional Control LeftRight Composite (%)

On Axis Velocity Left-Right
Composite (deg/s)
On-Axis Front-Back
Composite (deg/s)

53
5.10

7.80

COG Sway Velocity (cm/s)

2.23

4.10

1.40

52

57

52

4.90

15
0.60

Rise Index (% BW≥100%)

Rhythmic Weight Shift

0.25

1.20

0.50

Weight Transfer Time (s)

Sit to Stand

Eyes Close

Eyes Open

Unilateral Stance (COG Sway Velocity (deg/s)

35

0°
51

103.8

65.8

Weight Bearing Squat (%BW)

Speed (cm/s)

99.5

9.6
58.0

23.5

Max

Length (cm)

Min

Width (cm)

Walk Across

Test

Preoperative

42 (14)

1.55 (0.38)

43 (11)

82 (4)

86 (3)

4.02 (0.87)

5.96 (0.83)

3.40 (1.15)

28 (12)

0.59 (0.38)

2.13 (0.70)

0.81 (0.21)

45 (9)

45 (8)

43 (6)

46 (4)

84.1 (10.1)

79.8 (18.2)

17.8 (4.0)

Mean (SD)

0.92

0.95

0.88

0.66

0.45

0.84

0.93

0.55

0.98

0.35

0.78

0.78

0.87

0.42

0.54

0.32

0.62

0.99

0.76

ICC
(2,1)

4

0.08

4

2

2

0.35

0.22

0.77

2

0.31

0.33

0.10

3

6

4

3

6.3

0.8

1.9

SEM

34

0.95

25

54

79

2.80

5.00

1.30

8

0.15

1.20

0.60

39

40

39

43

68.3

58.2

7.6

Min

88

2.00

67

87

90

4.80

8.60

6.40

42

0.80

3.20

1.70

53

57

56

56

117.7

100.1

27.4

Max

54 (14)

1.41 (0.29)

49 (12)

75 (7)

86 (3)

3.76 (0.44)

6.05 (1.03)

4.48 (1.20)

23 (9)

0.27 (0.12)

1.98 (0.51)

0.89 (0.24)

47 (3)

46 (4)

46 (3)

48 (3)

90.8 (12.5)

83.1 (11.6)

17.8 (3.6)

Mean (SD)

12 Months Postoperative

0.84

0.89

0.98

0.52

0.80

0.75

0.91

0.58

0.90

0.41

0.74

0.74

0.34

0.65

0.14

0.55

0.82

0.92

0.68

ICC

5

0.09

2

5

1

0.22

0.31

0.78

3

0.09

0.26

0.12

3

3

3

2

5.4

3.3

2.0

SEM

49 (15)

1.47 (0.33)

46 (12)

78 (7)

86 (3)

3.86 (0.64)

6.02 (0.93)

4.02 (1.27)

25 (11)

0.41 (0.30)

2.05 (0.59)

0.86 (0.23)

46 (6)

46 (6)

45 (5)

47 (3)

88.4 (11.9)

81.9 (14.0)

17.8 (3.6)

Mean (SD)

0.89

0.92

0.93

0.62

0.62

0.82

0.92

0.61

0.94

0.48

0.77

0.75

0.75

0.49

0.38

0.47

0.76

0.96

0.68

ICC

All Patients Combined

Table 2.2 Descriptive Data and Reliability Statistics for Performance Based Assessments Among Autologous
Chondrocyte Implantation Patients Pre and 12 Months Post Operatively

5

0.09

3

4

2

0.27

0.27

0.79

3

0.22

0.28

0.12

3

4

4

2

5.0

2.7

2.1

SEM

47

94

231

1.75

34

54

155 (33)

1.38 (0.29)

25 (6)

47 (3)

0.82

0.94

0.84

0.79

14

0.07

2

1

88

0.85

13

38

224

2.14

38

56

131 (32)

1.22 (0.32)

24 (7)

48 (5)

0.90

0.91

0.75

0.85

10

0.10

3

2

141 (34)

1.29 (0.31)

24 (6)

48 (4)

0.88

0.93

0.78

0.84

See Table 2.1 for details regarding each variable. Standard Error of the Measurement (SEM); Intraclass Correlation Coefficient2,1 (ICC); Center of Gravity (COG);
Percentage of Body Weight (%BW).

*

Impulse (%BW x s)

0.82

17

Impact Index (% BW)

Time (s)

42

Distance (% height)

Forward Lunge

TABLE 2.2 (continued) Descriptive Data and Reliability Statistics for Performance Based Assessments Among
Autologous Chondrocyte Implantation Patients Pre and 12 Months Post Operatively

11.74

0.09

3

2

reliability (ICC≥0.75). For the Weight Bearing Squat only squatting at 90° of knee flexion
demonstrated acceptable reliability. Both eyes open and eyes closed Unilateral Stance on
the involved limb showed acceptable reliability. For the Sit-to-Stand only the rise force
met the reliability standard. Both left-right and front-back composite on axis velocity for
the Rhythmic Weight Shift were reliable. The Step Up/Over was reliable for lift-up index,
movement time, and impact index. Finally, distance, impact index, movement time, and
impulse were reliable for the Forward Lunge.

Preoperative vs. Postoperative
Among preoperative patients ICC values ranged from .32 to 0.99. Among patients
12 months post ACI, ICC values ranged from .14 to .98. The Weight Bearing Squat at 90°
was observed to be reliable in the preoperative group (ICC=0.87), but not in the
postoperative group (ICC=0.34). Walk Across speed (pre ICC=0.62, post ICC=0.82) and
Rhythmic Weight Shift left-right directional control composite score (pre ICC=0.45, post
ICC=0.80) were the only variables observed to have acceptable reliability in the
postoperative group but not in the preoperative group. For the remaining variables
observed to have acceptable reliability across groups ICC values differed by less than
0.10 between preoperative and postoperative patients.

DISCUSSION
The purpose of this study was to investigate the reliability of a series of tests using the
NeuroCom Balance Master® long force plate among knee cartilage patients. These tests
represent potential performance based outcomes to serially evaluate treatment progress
and success following ACI or other cartilage repair and restoration procedures. For each
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of the tests evaluated, at least one outcome variable was observed to have acceptable
reliability with ICC≥0.75. Overall the most reliable task was the Step Up/Over and the
least reliable task was the Weight Bearing Squat.
To our knowledge this is the first study to evaluate the reliability of LFP measures
in a pathologic knee population. NeuroCom International has previously reported
reliability among healthy participants for all of the tests evaluated with the exception of
the Rhythmic Weight Shift.3 This reliability consisted of Pearson product moment
correlation coefficients (r) calculated “by performing linear regression analysis.”3 One
limitation to the use of these simple linear analysis tests is that systematic differences
cannot be detected between testing sessions, which may occur due to a learning effect.
Other authors using the NeuroCom system have frequently referenced these correlation
values as being acceptable. 6, 180, 183 Despite the limitations of the NeuroCom International
data, the correlation coefficients they report are similar to those we observed with r values
ranging from 0.35 to 0.93.3
Elsewhere in the literature, “Good to excellent” 173 reliability for the unilateral
stance and forward lunge among healthy participants was referenced by Willems et al.184
Additionally, independent intertester and intratester reliability has been established in
active females for the Step-Up/Over and the Forward Lunge with ICC values ranging
from 0.59 to 0.93.119 It should be noted that the ability to interpret and generalize these
authors’ findings is limited due to the use of ICC equation (3,k). By definition reliability
calculated using model 3 is only applicable for the examiner for whom the reliability has
been calculated and cannot be generalized to other potential examiners.160 Finally, the use
of only healthy, female participants in this study limits its generalizability to more diverse
clinical populations including knee patients.
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Despite the differences between studies, a comparison between our results and
Naylor and Romani119 demonstrates similar reliability values, even in the presence of
different performance means. Both studies reported acceptable intratester reliability for
these measures. Compared to Naylor and Romani we observed slightly higher ICCs for
lift-up index (0.93 our study vs. 0.68 to 0.79) and impact index (0.89 our study vs. 0.83)
and identical values for movement time (0.92).119 Similar results were seen for the
Forward Lunge where ICCs ranging from 0.72 to 0.93 were observed, while Naylor and
Romani reported values from 0.71 to 0.93. Furthermore, differences between patients
with a known pathology and healthy participants represent a level of face validity for
these NeuroCom tests. For example, when comparing our results to those reported by
Naylor and Romani lower functional scores were observed among our pathologic patients
than their healthy female controls.119 During the Step Up/Over our patients demonstrated
lower lift-up index (46% vs 48% to 54%) and impact index values (49% vs. 55% to 65%),
but longer movement times (1.47s) compared to the healthy athletic female participants
(1.03 to 1.09s).119 During the Forward Lunge ACI patients demonstrated shorter lunge
distance (48% vs. 53% to 57%) and lower impact index (24% vs. 39 to 42%), but longer
movement time (1.29s vs. 0.73s to 0.77s) in comparison to those values reported among
healthy, athletic females.119 Despite these performance differences, similar reliability was
observed in our study compared to that previously reported for all forward lunge variables
with both studies demonstrating reliability above the 0.75 threshold for lunge distance,
impact index, movement time and impulse.
The outcome measures where reliability fell below the a priori threshold of 0.75
were Walk Across width; Weight Bearing Squat at 0°, 30°, and 60°; Sit to Stand weight
transfer time and center of gravity sway velocity; and the Rhythmic Weight Shift
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directional control moving left-right or front-back. For the Weight Bearing Squat the
variability of this task may be higher than the other tasks evaluated due to the nature of
the data collected. Unlike other measures where the average of three trials is recorded as
the outcome variable, per the NeuroCom protocol, only a single trial at each position is
recorded for the Weight Bearing Squat. Furthermore, the testing protocol for the Weight
Bearing Squat captures the percentage of weight bearing for only a single data point at the
time the test is initiated. The averaging of multiple trials at each position may improve the
reliability of this test. A similar effect may exist with the Rhythmic Weight Shift where
the computer software is designed to collect only one trial at each speed. Lower reliability
values were also observed for width of the Walk Across task (ICC=0.68). This task
demonstrated a learning effect as our participants had a 2.6 cm narrower stride during the
second testing session. Narrowing of the stride is considered to represent improved
function as an individual becomes comfortable with a narrower base of support.3
Therefore, this improvement may be a result of individuals becoming more comfortable
with the testing apparatus and laboratory environment over time, thus reducing our
reliability values. Since the Walk Across was the first overall test, the reliability of this
test may be improved by providing participants with more time to acclimate to the testing
procedures.
One goal of this study was to examine the reliability of LFP tasks across levels of
function within the same patient population. This was investigated by including both
preoperative and 12 month postoperative patients in the study population. Although there
were some differences in reliability between preoperative and postoperative groups, in
general outcome measures that were observed to be reliable in one group were reliable in
the other. The exceptions to this were the Walk Across speed, Weight Bearing Squat at
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90°, and Rhythmic Weight Shift right-left directional control composite score. Each of
these had ICC values ranging from 0.62 to 0.76 when examined across groups and
potential threats to reliability that have already been discussed. Specifically, the Walk
Across and Rhythmic Weight Shift reliability may have increased over time due to a
potential learning effect among 12 month patients who had more experience with these
tasks due to previous exposure as part of an ongoing outcomes study. Overall for each
task, with the exception of the Weight Bearing Squat, at least one outcome variable was
observed to have acceptable reliability among both preoperative and postoperative
patients.

Limitations
Patients were evaluated preoperatively and one year postoperatively, hence
reliability at interim time points cannot be assessed. Reliability was assessed intraday as it
was anticipated that the greatest threat to reliability would be a learning effect for the tests
utilized, hence any interday affects have not been investigated. In this study we examined
reliability of the long force plate measures, and did not evaluate the responsiveness of
these measures to treatment progress.

CONCLUSION
PBAs have the potential to provide further insight into patient outcomes following
ACI. However, PBAs must be reliable to be effective for evaluating patient progress over
time. The NeuroCom Balance Master® Long Force Plate is capable of reliably evaluating
ACI patient performance of movements utilized during ADLs. Lower extremity function
was most reliably assessed by the step up/over and lunge tasks for which ICC values
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ranged from 0.78 to 0.93, demonstrating consistent evaluation in a pathologic knee
population. Additionally, select outcome variables associated with the Walk Across,
Weight Bearing Squat, Unilateral Stance, Sit to Stand, and Rhythmic Weight Shift were
also observed to have acceptable reliability (ICC≥0.75). Furthermore, this instrument
demonstrated reliability across a variety of levels of function among both preoperative
patients and those one year post ACI surgery.
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CHAPTER 3: PATIENT ORIENTED AND PERFORMANCE BASED OUTCOMES
FOLLOWING KNEE AUTOLOGOUS CHONDROCYTE IMPLANTATION

INTRODUCTION
Autologous chondrocyte implantation (ACI)28 has become an acceptable and
common treatment approach for the management of symptomatic articular cartilage
defects.61 As research regarding ACI has advanced sizable efforts have been made to
evaluate both disease and patient oriented outcomes following ACI. Numerous studies
have evaluated the utilization of patient reported outcomes (PROs) to document the
recovery of function and return to activity following ACI.74 Meta-analyses of more than
43 studies have revealed large effect sizes demonstrating significant improvement for a
variety of PRO scores following ACI.74 PROs provide reliable and valid information
regarding patients’ perceived function and health related quality of life (HRQL). An
alternative to PROs is the use of performance based assessments (PBAs) to document
outcomes. PBAs provide a direct, objective measure of patient function and involve
measures of performance such as time, distance, or force for specified tasks or
movements. The relationship between PROs and PBAs has previously been reported as
low to moderate among a variety of knee patients.52, 79, 82, 117, 120, 159 Recent research
involving total joint arthroplasty patients has provided further support for the inclusion of
PBAs as part of a detailed outcomes assessment protocol.79, 117, 166 The combining of
PROs with PBAs may provide a more complete picture of clinical outcomes after ACI
than the utilization of either type of outcome in isolation.
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Few studies have utilized PBAs to document the return of function following ACI.
Those that have, have either examined very low demand activity such as the 6 minute
walk test,44, 45, 146 or very high demand activity via the single-limb hop.172 No known
studies have examined the timeline for return to function following ACI using low to
moderate demand PBAs that recreate the demands and stresses of common activities of
daily living such as squatting, rising from sitting, or going up and down stairs, in addition
to walking. Nor has the relationship between PROs and PBAs been examined in an ACI
patient population. An accurate description of functional recovery during the first year
following ACI is imperative to provide evidence for prescription of appropriate patient
education, rehabilitation protocols, and understanding of the recovery process.
Furthermore, an understanding of the relationship between PROs and PBAs will provide
key information regarding the importance of collecting varying types of outcomes in
future cartilage repair research. At present PROs are the accepted standard for functional
outcomes in cartilage research; however, if PRO scores are not correlated with PBAs then
both outcome measures may be necessary to document both perceived and physical
changes in patient function following ACI. Therefore, the purpose of this study was to
document serial changes in knee function over one year following ACI using both PROs
and PBAs and to explore the relationship between PROs and PBAs during recovery
following ACI. It was hypothesized that PROs would demonstrate significant
improvement from baseline at all postoperative time points. It was also hypothesized that
PBA measures for walking, rising from sitting, stepping up/over, and lunging would
demonstrate no improvements at the 3 month time point followed by progressive
improvement at 6 months and 12 months as compared to baseline measures of function.
Finally, it was hypothesized that a significant relationship (P ≤ 0.05) would exist between
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all PRO scores and performance measures for walking, rising from sitting, stepping
up/over, and lunging at all time points with both forms of assessment demonstrating
positive improvements over time.

METHODS
Patients
Beginning in July 2009 patients were prospectively recruited from an active
cartilage center. Inclusion criteria were planned ACI surgery to the medial or lateral
femoral condyle, trochlea, or patella; willingness to participate and no uncorrectable
contraindications to ACI such as extensive degenerative joint disease, insufficient
meniscus, or unstable knee; and ability to ambulate without use of assistive devices.
There were no exclusions based on limb malalignment if the malalignment was corrected
prior to or at the time of surgery via high tibial osteotomy or tibial tubercle transfer.
Similarly, patients undergoing concomitant or staged ligament reconstruction to correct
joint instability were also eligible for study participation. Patients undergoing
concomitant meniscal transplant were excluded.
A total of 29 patients (17 males, 12 females, 36.3 ± 6.9 yrs, 174.4 ± 9.6 cm, 90.4 ±
19.4 kg) agreed to participate. Three patients were invited to take part of the study, but
declined to participate resulting in an enrollment rate of 90%. Of the enrolled patients 13
underwent ACI to the patellofemoral joint with a tibial tubercle transfer and the remaining
16 underwent ACI to the medial femoral condyle, of which 4 also had a concomitant high
tibial osteotomy. Mean number of defects treated per patient were 1.38 ± 0.6 with an
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average treatment area of 6.6 ± 2.5 cm2 (range 2.3 to 13.0 cm2). All participants signed a
university approved IRB consent form at the time of enrollment.

Surgical Procedures and Rehabilitation
All patients underwent a two-step ACI procedure performed by the same surgeon
(CL). During the first procedure a limited chondroplasty was performed and the lesion
was evaluated arthroscopically. At this time a biopsy was obtained from the intracondylar
notch (100 to 200 mg cartilage). This sample was sent to a commercial laboratory where
it was cultured and expanded (Carticel, Genzyme Corp, Cambridge, MA). In a second
surgical procedure chondrocyte implantation was performed using a miniarthrotomy. First the defect or defects were prepared using a curette to debride down to
the subchondral plate with stable edges. A type I/III collagen membrane (ChondroGide (R) , Geistlich Biomaterials, Wohousen, Switzerland) was shaped to match the
defect. Sutures and fibrin glue (Tisseel, Baxter Healthcare Corp., Deerfield, IL) were
used to adhere the membrane over the defect to form a water tight seal. The chondrocytes
in suspension were then injected beneath the membrane into the defect through a small
portal remaining at the edge of the collagen membrane. The portal was then closed and
sealed with sutures and additional fibrin glue.
All patients followed standardized rehabilitation protocols following surgery.93
All patients were braced in full extension and were non-weight bearing for 2 weeks
postoperatively. Toe-touch weight bearing was permitted from 2 to 4 weeks with partial
weight bearing from 4 to 6 weeks and progression to full weight bearing between weeks 6
to 12. Continuous passive motion was prescribed for all patients for 6 to 8 hours per day
for 6 weeks. For defects in the tibiofemoral joint knee braces were gradually unlocked
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between 2 to 4 weeks as quadriceps control was gained. For defects to the patellofemoral
joint knees were braced in full extension for weight bearing through 4 weeks
postoperative and then were gradually unlocked as quadriceps control was gained
between weeks 4 and 6. Once good quadriceps control was gained all patients were
transitioned to a hinged knee sleeve. All patients were recommended to abstain from high
intensity cutting or pivoting activity until at least 12 months post ACI.

Patient Reported Outcomes
The PROs used in this study were the Medical Outcomes Study – 36 Item Short
Form Health Survey Physical Component Scales (SF-36 PCS),105, 106, 179 the Western
Ontario and McMaster Osteoarthritis Index (WOMAC),18 the International Knee
Documentation Committee (IKDC) Subjective Knee Evaluation Form,77 and the Lysholm
scale.96 The SF-36,58 IKDC,58 Lysholm, 85 and WOMAC58, 85 have all been evaluated for
reliability among cartilage patients. The SF-36 PCS was included to serve as a measure
of HRQL. The IKDC and Lysholm are region specific instruments that focus on knee
function, while the WOMAC is a disease specific instrument focusing on degenerative
joint disease covering pain, stiffness, and function. A researcher independent of the
treating physician reviewed each instrument with the patients and was available to answer
any questions they may have had. All PROs were completed at the following time points:
prior to implantation (preoperation), 3 months, 6 months, and 12 months post-surgery.

Performance Based Assessments
At each time point after completing PROs each participant completed a series of 6
PBAs in a musculoskeletal laboratory setting. All PBAs were completed using the
NeuroCom Balance Master® and long force plate (LFP) (NeuroCom International,
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Clackamas, OR). This is a commercially available system designed both as a training
and evaluation tool for function and balance tasks, and it has the ability to provide
immediate feedback to clinicians and patients regarding quality of task performance for a
variety of activities of daily living (ADLs).5
The LFP consists of a 45.72 cm x 152.40 cm force plate with data sampled at 100
Hz and a personal computer equipped with data capture software (Balance Master ver.
8.1). These functional tasks were selected because of their direct relationship to activities
of daily living and the feasibility of patients being able to complete the task at each testing
time point (Table 2.1). Tests were completed in the order presented at all time points.
This order was subjectively determined during pilot testing to be from least to most
demanding. All testing was administered by the same investigator (JSH). For all single
limb tests the uninvolved limb was tested first. Three successful trials of each task were
performed (except for the Weight Bearing Squat which consisted of a single trial at each
joint angle). Approximately 15s of rest was permitted between each trial and 30s of rest
between each task. For the purposes of this manuscript all outcome variables are
identified using the names assigned to them by the software utilized. Definitions for these
variables are presented in Table 2.1. The six tasks are described below.
Walk Across: Patients walked across the LFP using their freely chosen standard gait speed
and pattern.
Weight Bearing Squat: Patients stood still on the force plate at the initial measure was
recorded with knee flexion angles of 0˚, 30˚, 60˚, and 90˚as tolerated 0˚). They then
flexed their knees and held positions at 30˚, 60˚, and 90˚as tolerated. The percentage of
body weight on the involved limb was measured during a single trial with a duration .01s
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for each position. A standard goniometer was used to verify knee joint angle at each
position.
Unilateral Stance: Patients stood on each leg and maintained their balance for 10 s with
their eyes open. They begin with the non-weight bearing leg flexed at about 60-80˚ and
with their hands on their hips. If patients touched down, or their legs touched each other,
testing was stopped and the trial was discarded. Testing of a condition was discontinued if
a participant experienced three consecutive failed trials. Testing was repeated for both
legs with the patients’ eyes closed.
Sit to Stand: Patients were seated on a 50cm box. Upon both visual and audio signal from
the computer they rose to full standing as quickly as possible without using their hands,
and then maintained a steady stance for the remainder of the 10 s trial.
Step-Up/Over: Participants stood behind a 29cm high box and stepped up onto the box
with their test leg, then brought their non-test leg up and over the box, and then stepped
down with their test leg. This was performed as quickly as possible while still maintaining
control.
Forward Lunge: Patients in a standing position stepped forward on one leg and squatted
down as far as comfortably possible, and then returned to the initial standing position as
quickly as possible.

Statistical Analysis
Separate repeated measures ANOVAs were used to compare changes in PROs and
each force plate assessment between preoperative, 3 month, 6 month, and 12 month
postoperative evaluations. The significance level was set at p< 0.05 a priori and when a
main effect for time was evident pairwise comparisons with a Bonferonni adjustment to
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correct for multiple comparisons were used to identify differences between individual
time points. In addition to evaluating for statistical differences, changes between
performance values at the preoperative time point and each follow-up time point were
also compared to minimal detectable change (MDC) values. The MDC values were
calculated from a concurrent study evaluating the reliability of long force plate measures
in ACI patients (Chapter 2).73 A Pearson product moment correlation was used to
examine the relationship between PROs and PBAs at each time point. Relationships with
R-values above .90 were considered to have a high correlation, 0.71 to 0.90 was
moderate, and 0.40 to 0.71 was low.169 For all correlations a significance level of p ≤
0.05 was set a priori.

RESULTS
Six participants were declared clinical failures at or before the one year time point
and were not medically cleared to complete functional testing at all time points. An
additional five participants were lost to follow-up. Finally, one participant failed to
complete preoperative force plate testing and another participant was lost to follow-up at
the 6 month time point, but returned to the study at the 12 month time point. As a result
full PBA data was only available for 16 subjects. Full PRO data was available for 21
patients including 4 patients who were declared failures at the 12 month time point.

Patient Reported Outcomes
There was a main effect for time for all four PRO instruments (Figure 3.1). There
were significant improvements from preoperation to 12 month follow-up for the IKDC (p
= 0.012), SF36-PCS (p = 0.011), Lysholm (p = 0.002), and WOMAC (p = 0.013). The
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IKDC (p = 0.50) and the Lysholm (p = 0.008) also improved significantly between
preoperation and 6 months postoperatively. There were no significant changes between
preoperation and the 3 month time point for any of the PRO instruments.

Figure 3.1. Patient Reported Outcome Scores
100
90

*

*

80

*

*

70
60

*

*

50

*

40
30
20
10
0
Preoperative

3 months
IKDC

SF-36 PCS

6 moths
Lysholm

12 months
WOMAC

*p < 0.05 compared to preoperative time point. IKDC and Lysholm are scored from 0 to
100 with 100 representing and ideal score. SF-36 PCS uses norm based scoring system
where 50 represents a mean score with a standard deviation of 10 and higher scores
representing higher levels of function. The WOMAC is scored 96-0 with 0 representing
an ideal score.
Performance Based Assessments
The only PBAs to demonstrate changes over time were the Walk Across, Weight
Bearing Squat, and Step Up/Over (Table 3.1). There was a significant increase in stride
length observed between the 3 month and 6 month time points (p = 0.025) for the Walk
Across task. There were no significant changes in stride width or walking speed. For the
Weight Bearing Squat a main effect for time was observed for squatting at 30⁰, 60⁰, and
90⁰. Post-hoc analysis revealed decreases in weight distribution on the surgical limb
between preoperation (50% body weight) and 3 months (45% body weight, p = 0.05) for
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Test Variable
Walk Across
Width (% height)
10.1
1.9
Length (%height)
42.3
7.2
Speed (cm/s)
78.5
9.6
Double Limb Squat (% Body Weight (BW))
0⁰
49
3
30⁰
50
3
60⁰
50
4
90⁰
52
6
Unilateral Stance (Center of Gravity(COG) Sway Velocity (deg/s)
Eyes Open
0.88
0.33
Eyes Close
1.76
0.60
Sit to Stand
Weight Transfer Time (s)
0.38
0.38
Rise Index (% BW>100%)
25.2
9.9
COG Sway Velocity (cm/s)
4.12
1.19
Inv/Uninv Symmetry (-towards uninvolved)
-2.67
16.77
Step Up/Over
Lift-up Index (% BW>100%)
39.8
10.3
Time (s)
1.39
0.25
Impact (% BW)
50.2
13.8
Forward Lunge
Distance (% height)
45.8
7.1
Impact Index (% BW)
24.4
7.4
Time (s)
1.23
0.38

Preoperative
Standard
Mean
Deviation

2
5
5
5
0.16
3.48
0.27
7.1
1.50
14.28
12.1
0.67
20.5
6.4
6.4
0.60

48
45*
43*
‡
45
0.88
2.99
0.39
21.7
4.80
-11.27
47.9
‡
1.67
54.0
45.0
21.8
‡
1.52

‡

1.6
10.3
17.1

10.6
41.8
84.4

3 Months
Standard
Mean
Deviation

48.3
24.0
1.33

*‡

50.0
1.44
59.6

0.39
24.5
4.56
-10.67

0.83
1.79

49
46
44*
48

9.6
†‡
47.5
85.7

Mean

6 Months

5.9
4.9
0.19

12.1
0.28
21.0

0.27
7.5
1.81
8.24

0.21
0.36

3
5
5
6

1.9
7.1
21.8

Standard
Deviation

47.5
23.9
1.29

‡

48.2
1.40
56.5

0.29
25.5
4.30
-7.33

0.83
1.84

48
46
46
48

9.8
‡
48.3
*‡
93.6

5.4
7.5
0.31

10.1
0.28
14.4

0.10
8.6
1.25
9.08

0.30
0.50

3
3
4
4

2.4
6.4
11.4

12 Months
Standard
Mean
Deviation

3.2
5.8
0.17

6.0
0.18
9.7

0.43
5.04
1.56
11.16

0.23
0.21

5
8
8
6

2.3
3.0
11.50

Minimal
Detectable
Change

Table 3.1. Patient Reported and Performance Based Assessments Over 12 Months Following Autologous Chondrocyte
Implantation
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3 Months
Standard
Mean
Deviation

6 Months
Standard
Deviation

12 Months
Standard
Mean
Deviation

Test Variable
Mean
Patient Reported Outcomes
IKDC
40.48
14.26
43.96
14.94
52.41*
18.98
54.87*
20.10
SF-36 PCS
37.05
10.25
40.01
9.60
43.49*
10.07
43.04*
10.54
Lysholm
47
22
55
23
64*
23
66*
24
WOMAC
32
19
27
19
22
21
20*
20
*significantly different from preoperative time point, †significantly different from 3 month time point, ‡Change from preoperative greater than MDC

Preoperative
Standard
Mean
Deviation

13.70
58
6.60
85
15.80
58
15.30

58

Minimal
Detectable
Change

Table 3.1. (continued) Patient Reported and Performance Based Assessments Over 12 Months Following Autologous
Chondrocyte Implantation

squatting at 30⁰. Decreases were also observed between preoperation and 3 months (p =
0.002) and preoperation and 6 months (p = 0.02) for squatting at 60⁰. At both the 3
month time point (43% body weight) and the 6 month time point (44% body weight) a
lower percentage of body weight was placed on the surgical limb compared to squatting at
the preoperative time point (50% body weight). Although not statistically different from
preoperative values, at the 12 month time point mean weight distribution remained below
preoperative values at 0⁰ (49 + 3% vs. 48 + 3%), 30⁰ (50 + 3% vs. 46 + 5%), 60⁰ (50 +
3% vs. 46 + 5%), and 90⁰ (52 + 6% vs. 48 + 4%). Finally, there were significant
increases in lift-up force between preoperation (40 + 10% body weight) and 6 months (50
+ 12% body weight) for the Step Up/Over. No other Step Up/Over variables changed
significantly over one year following ACI.
Comparison of changes between preoperative and postoperative follow-up values
to MDC values demonstrated measurable changes in performance for the Walk Across,
Weight Bearing Squat, Step Up/Over, and Forward Lunge (Table 3.1). Between
preoperation and the 3 month time point measurable decreases in weight distribution (7%
body weight) on the involved limb were observed for squatting at 90⁰. During the same
time period increases were observed for lift-up force (8.1% body weight) and
performance time (0.28s) for the Step Up/Over, and for performance time (0.29s) for the
Forward Lunge. Between preoperation and the 6 month time point Walk Across stride
length increased by 5.2% of body height and Step Up/Over lift-up index increased by
11.2%. Finally, between preoperation and the 12 month follow-up Walk Across stride
length increased by 6% of body height while walking speed increased by 15.1 cm/s and
Step Up/Over lift-up index increased by 8.16% body weight.

65

Relationship Between Patient Reported Outcomes and Performance Based
Assessments
Across all time points there were 54 significant correlations with absolute R
values ranging from 0.38 to 0.73. All significant correlations are presented in Table 3.2.
Correlations occurred between each of the four evaluated PROs and the Walk Across,
Unilateral Stance, Weight Bearing Squat, Sit-to-Stand and Forward Lunge functional
tasks. At no time point did any of the PROs correlate to outcome measures for the Step
Up/Over. Among PBA outcome measures there were 14 measures correlated to the
IKDC score at varying time points (absolute R value range: 0.38 to 0.61), 18 to SF-36
PCS score (0.38 to 0.73), 8 to Lysholm score (0.38 to 0.64), and 14 to total WOMAC
score (0.38 to 0.64). There were 17 correlations between PRO scores and PBA outcome
measures at the preoperative time point (0.38 to 0.66), 7 at the 3 month time point (0.45 to
0.72), 10 at the 6 month time point (0.44 to 0.66), and 20 at the 12 month time point (0.48
to 0.73). There were no PRO scores or PBA measures that were consistently correlated to
each other across all 4 time points.

DISCUSSION
The primary purpose of this study was to provide a timeline for recovery that
could be utilized by both patients and physicians in managing expectations regarding
postoperative recovery of function. A summary timeline of the functional recovery
observed in the first year following ACI can be seen in Figure 3.2. Improvements in
patients’ self-reported function were observed as early as 6 months following ACI using
the IKDC and Lysholm outcome scores. In addition to these PROs, the SF-36 PCS and
WOMAC also demonstrated improvements one year following ACI. In contrast, some
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Table 3.2. Correlations Between Performance Based Assessments and
Patient Reported Outcomes By Follow-up Time Point
Task
Walk Across
Width
Length
Speed

IKDC

Preoperative
SF-36
WOMAC
PCS

Lysholm

IKDC

3 Months Postoperative
SF-36
WOMAC
Lysholm
PCS

-

-0.38

0.50*

-

-

-0.50

-

-

0.43

0.47

-0.66*

-

-

-

-

-

0.38

-

-

-

-

-

-0.45

-

Weight Bearing Squat
0 degrees
-

-

-

0.38

-

-

-

-

30 degrees

0.42

-

-0.46

0.53*

-

-

-

-

60 degrees

-

-

-

0.46

-

-

-

-

-0.44

-

-

-

-

-

-

-0.46

-

-

-

-

-

-

-

-

-

-0.38

-

-

-

-

-

-

0.40*

-

-

-

0.49

-

-

-

-

-

-

-

-

-

-

Lunge
Impact Index

-

0.45

-

-

0.53*

0.72*

-0.51*

-

Distance

-

-

-

-

-

0.50

-

-

Time

-

-

-

0.51

-

-

-

-

Unilateral Stance
Eyes open
COG Sway
Eyes closed
COG SV
Sit-to-Stand
Rise Force
Involved/
Uninvolved
rise
symmetry
COG Sway

All presented correlations are significant at the p < 0.05l level, *p< 0.01)
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Table 3.2. (continued) Correlations Between Performance Based
Assessments and Patient Reported Outcomes By Follow-up Time Point
Task

6 Months Postoperative
IKDC
SF-36
WOMAC
PCS

Lysholm

IKDC

12 Months Postoperative
SF-36
WOMAC
Lysholm
PCS

Walk Across
Width

-

-

-

-

-

-

-

-

Length

-

-

-

-

-

-

-

-

Weight Bearing Squat

-

-

-

0.58

0.56

-0.54

-

Speed

0 degrees

-

-

-

-

-

-

-

-

30 degrees

0.44

0.59*

-0.52

-

-

-

-

-

60 degrees

-

-

-

-

-

-

-

-

-

-

-

-

-0.54

-0.67*

0.64*

-0.64*

-

-

-

-

-0.59*

-0.73*

0.58

-0.64*

-

-

-

-

-

-

-

-

-

-

-

-

0.61*

0.61*

-0.63*

0.50

-

-

-

-

-0.51

-

-

-

Impact Index

0.62*

0.60*

-0.66*

0.61*

-

-

-

-

Distance

0.45

0.45

-0.51

-

-

-

-

-

-

-

-

-

-

-0.48

-

-

Unilateral Stance
Eyes open
COG Sway
Eyes closed
COG SV
Sit-to-Stand
Rise Force
Involved/
Uninvolved
rise
symmetry
COG Sway
Lunge

Time

All presented correlations are significant at the p < 0.05l level, *p< 0.01)

decreases in performance based function relative to preoperative values were seen at the 3
and 6 month time points with decreased performance values for squatting, lunging, and
stepping. Beginning at 6 months, increases in stride speed and length were observed;
however, the difference between performance time for the involved side relative to the
uninvolved side was greater at the 12 month time point than at the preoperative time point
for the Step Up/Over. Overall, these results suggest that patients may experience
physical benefits such as decreased pain and symptoms as early as 6 months following
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ACI, but significant improvement in functional performance of complex tasks such as
squatting, stepping, and lunging may not occur until 12 months or longer following ACI.
Figure 3.2. Timeline of Functional Recovery Following Autologous Chondrocyte
Implantation
3 Months Post ACI
• No significant
improvement in selfreported function
• Increased asymmetry
of weight
distribution during
squatting
• Measurably longer
time required to
complete tasks such
as lunging or going
up or down steps
• Increased lift-up
force when stepping
up onto curbs or
steps

6 Months Post ACI

12 Months Post ACI

• Some significant
improvements in
self-reported
function
• Continued
asymmetry of weight
distribution during
squatting
• Improved stride
length
• Continued Increases
in lift-up force when
stepping up onto
curbs or steps
• Slowed stepping
time on involved
side relative to
uninvolved

• Noticeable
improvement in all
measures of selfreported function
• Measurable increases
in stride length
• Significant increase
in speed when
walking
• Side to side
differences in
stepping time are
greater than
preoperation with the
involved side taking
longer than the
uninvolved side

Patient Reported Outcomes
PROs have frequently been utilized to report functional outcomes following ACI.
The observed results suggest that patients should not expect significant improvement prior
to the 6 month time point, and that in some cases, such as with the WOMAC,
improvements may not be appreciable until one year post ACI. The lack of significant
improvement in PRO scores at the 3 month time point is in agreement with previous
research by Henderson and Levigne and Ebert et al. 44, 67 However, both of these authors
observed decreases in self-reported function using the IKDC67 and SF-36 PCS44, 67 at the
three month time point, while we observed slight, but non-significant increases. In
contrast Tohyama et al. did observe significant improvements in Lysholm scores as early
as 3 months following treatment with atelocollagen-associated ACI.171
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The improvements observed among patients in IKDC, Lysholm, and SF-36 PCS
scores at 6 months were similar to the outcomes observed by Niemeyer et al. for the
IKDC122 and both Niemeyer et al. and Kreuz et al. for the Lysholm.89, 122 Other authors
have observed even larger improvements in IKDC171 and Lysholm14 scores as early 6
months following ACI. The failure to observe improvements in the WOMAC at the 6
month time point in the current study is similar to other authors observations of no
improvement at 6 months in IKDC67, 89 or SF-36 PCS67 scores. There have been no
reports of WOMAC scores for periods of less than 1 year for comparison to the present
results.
Across all PROs we observed improvements when preoperative scores were
compared to scores 12 months following ACI surgery. These results are in agreement
with the findings of others when utilizing the IKDC,42, 65, 67, 89, 121, 122, 158, 186 Lysholm,89,
121, 122, 171, 186

SF-36 PCS,67 and WOMAC111, 113 scores 1-year following ACI. Regardless

of which outcome instrument is used, the IKDC, Lysholm, SF-36 PCS, or the WOMAC,
both clinicians and patients can anticipate improvements in self-perceived function during
the first year following ACI.

Performance Based Assessments
Limited improvements in PBAs were observed 1-year following ACI (Table 3.2.).
In general, a decrease in physical performance was observed at 3 and 6 months
postoperatively, followed by a return towards baseline at 12 months following ACI. This
pattern of decreased function followed by gradual return of function was particularly true
for the Weight Bearing Squat, Step Up/Over, and Lunge. The only measures to show
positive improvements at or within the 12 month time point were Walk Across stride
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length and speed, and Step Up/Over lift-up index. These results suggest that
improvements for simpler, less demanding tasks, such as walking or going up steps can be
seen as early as 6 to 12 months following ACI. However, for more complex tasks,
particularly those that require eccentric quadriceps control - such as squatting, going
down steps, or lunging - meaningful changes in function may not be observed within the
first year following ACI. From the results of this study it is unclear as to whether further
improvements in function, particularly for more complex tasks occurs over long-term
follow-up following ACI.
Decreases in physical performance at the 3 month time point have been previously
observed with the 6 minute walk-test following matrix-induced autologous chondrocyte
implantation (MACI)44, 45 and characterized chondrocyte implantation (CCI).146 Similar
to our results, other researchers have observed slight improvements in walking
performances at the 6 month45 and 12 month45, 146 time points that continue to improve at
24 month follow-up.45, 146 During laboratory gait analysis improvements in gait speed and
stride length, without significant changes in stride width, were observed over 12 months
following MACI.43 These results support our observation that, after an initial decrease in
function, both patients and physicians can anticipate improvements in gait beginning
around the 6 month time point following ACI.
In examining more dynamic tasks, Van Assche et al. observed deceased functional
performance for a series of hopping and strength tasks (single-limb hop, cross-over hop, 6
m timed hop, and isometric knee extension strength) at 6 months following CCI and no
significant improvements were observed as late as 24 months after CCI.172 For example,
these authors observed a 9% decrease in the single-leg hopping limb symmetry index
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through 24 months following surgery.172 These results are in agreement with our
observations demonstrating an initial decrease in function for more dynamic tasks such as
squatting, stepping, and lunging with few or no significant or measurable improvements
in functional performance at the 12 month time point following ACI.
Normative values for some LFP variables for the Weight Bearing Squat,
Unilateral Stance, Step Up/Over, and Forward Lunge have been published by the system
manufacturer.3 This normative data is presented by age group with individuals ages 20 to
39 (n = 74) and individuals ages 40 to 59 (n = 47) being the most appropriate groups for
comparison to the current cohort. In comparing values observed in the present study to
this historical data from healthy individuals some general observations can be made. For
the Weight Bearing Squat normative data is only available for the standing (0⁰) position.
Normative values for weight asymmetry in this position ranged from 0.6 ± 3.1% to 1.4 ±
3.1% body weight. These values were similar to those seen for ACI patents with
asymmetries ranging from 0.7 ± 3.0 % (at 6 months) to 2.4 ± 2.3% (at 3 months). For the
Unilateral Stance the values observed among ACI patients throughout treatment for both
the eyes open (0.8 ± 0.2 to 0.9 ± 0.3 deg/s) and closed (1.8 ± 0.6 to 3.0 ± 3.5 deg/s)
conditions were similar to those observed among both normative age groups (eyes open:
0.7 ± 0.1 to 0.9 ± 0.3, eyes closed 1.9 ± 0.7 to 2.9 ± 1.1 deg/s). For the Step Up/Over lift
up index preoperative values (39.8 ± 10.3% body weight) began below normative values
(46.9 ± 14.1 % body weight to 50.2 ± 15.5 % body weight) but rose to normative values at
all follow-up time points ranging from 47.9 ± 12.1% body weight at 3 months to 50.0 ±
12.1% body weight at 6 months. Similar values were also observed between ACI patients
and healthy norms for Step Up/Over impact index. However, normative data for Step
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Up/Over time (1.20 ± 0.2s to 1.3 ± 0.3s) trended to be lower than ACI patients at any time
point (1.4 ± 0.3s to 1.7 ± 0.7s). For the Forward Lunge, impact index (21.8% ± 6.5%
body weight to 24.4 ± 7.4 % body weight) was lower at all testing points compared to the
normative data (36.0 ± 14.6% body weight to 42.2 ± 15.3 % body weight). Also, Forward
Lunge contact time was slower in ACI patients (1.2 ± 0.4s to 1.5 ± 0.6s) than has been
previously reported among healthy individuals (1.0 ± 0.2s to 1.1 ± 0.2s). One variable
that did approach normative values (48.3 ± 8.6% height to 53.4 ± 7.8% height) was
Forward Lunge distance which increased from 45.8 ± 7.1% height at preoperation to 48.3
± 5.9% height at the 6 month time point.
In comparison to normative data3 it can be observed that some LFP variables were
normal at baseline and return to that level by the 12 month time point. These include the
Weight Bearing Squat at 0⁰, Single limb stance, and Step Up/Over impact index. Other
variables including the Step Up/Over lift-up index and Forward Lunge distances are
below normative values preoperatively but increase to normal ranges by 12 months
postoperative. Finally, some variables are below normal ranges preoperatively and
remain so at the 12 month time point. These include the Step Up/Over time and Forward
Lunge time and impact index.
Across the literature and within our study sample, improvements in gait relative to
the preoperative time point have been observed as early as 6 months following ACI.
However, improvements in more dynamic activities such as squatting, lunging, stepping,
and hopping have not been observed within the first 12 months following ACI in the
present study or elsewhere. These results support existing theory that although
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improvements in self-report measures may occur early postoperatively, maximal defect
healing and functional improvement continues beyond 12 months following ACI. 22, 90, 145

Relationship Between Patient Reported Outcomes and Performance Based
Outcomes
Low to moderate correlations were observed between various PROs and PBAs at
each of the 4 time points with no PRO/PBA pairing correlating consistently across all
time points. The limited relationships observed between PROs and PBAs among ACI
patients is similar to that which has been previously reported among patients with other
lower extremity pathologies. Among anterior cruciate ligament patients (ACL)120, 144
IKDC scores have been observed to have little (R=.28) 159 to no82 relationship to singleleg hop, triple hop, cross-over triple hop, or vertical jump performance. Similarly, the
Lysholm has been observed to have a low (R = 0.36)159 to non-significant52, 120 correlation
to the single-leg hop or figure 8 run among ACL patients. In a longitudinal study of total
knee patients Mizner et al. observed low and variable correlations (R= -0.07 to -0.29)
between the SF-36 bodily pain subscale and performance on the six-minute walk test,
timed up and go test, and stair climbing test.117 These patients were evaluated
preoperatively and 1 month and 12 months postoperatively. Similar to the present study,
none of the correlations between the SF-36 bodily pain scale and the performance
measures were consistently significant across time points.117 Finally, in the only other
study reporting the relationship between a LFP assessment and a PRO, Jacobs et al. did
not observe a significant relationship pre or postoperatively between a modified Step
Up/Over lift-up index and Knee Society pain or function scores.79 Despite our attempts to
select PBAs that included activities addressed in the PROs (Ex. walking, going up and
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down steps, rising from sitting, and squatting) no consistent relationships were observed
between these two methods of assessing function.
Overall the results of this study suggest poor concurrent validity between PROs
and PBAs. It has been proposed that PRO instruments may be disproportionately
influenced by pain,79, 97, 165, 166 and this is one possible explanation for the slight trend of
improvement in PRO scores observed as early as 3 months (Figure 3.1) despite significant
decreases in physical function. These findings are in agreement with the work of Mizner
et al.117 and Parent and Moffett134 both of which observed that in the acute phase of
recovery following total knee arthroplasty patients subjectively over estimated their
functional capabilities. Similar to the present study, improvement or no change in PRO
scores was observed during early postoperative follow-up despite concurrent decreases in
objective measures of physical performance.117, 134
The variability of the correlations across time in this study and elsewhere is
particularly important and suggests that different latent variables may contribute to the
self-appraisal process used to complete PRO forms at varying times during clinical
follow-up. These variations in appraisal criteria are in agreement with response shift
theory which proposes that over time changes in personal evaluation standards and
perspective may result in changes to self-evaluation scores independent of true physical
changes in function.139, 163 One proposed solution to the disconnect between PROs and
PBAs is that patients complete some form of PBA prior to completing PROs.40 This
methodology provides patients with an additional sample of experiences from which to
evaluate their physical capabilities and may improve the accuracy of the self-appraisal
process.139 In the present study we chose to have patients complete all PROs prior to
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testing PBAs. This was done so that PBA performance would not influence PRO scores,
and our results could be compared to other ACI outcome studies which to date have
predominantly utilized PRO scores as primary outcome measures and have rarely
included PBAs. However, our results support the use of both forms of assessment when
evaluating changes in function following ACI. Furthermore, future research should
consider evaluating PBAs prior to having patients complete PROs to possibly improve
PRO accuracy and better describe post-operative changes in function.

Limitations
A limitation of this study is the inclusion of a diverse ACI patient population. The
study sample included individuals undergoing treatment for lesions to the patella,
trochlea, and/or femoral condyle many of which also underwent concomitant realignment
procedures. Because of this variability, the presented timeline for recovery is not specific
or precise for any one defect location and/or realignment procedure. Instead a broad
pattern of recovery has been presented that can be generalized to a variety of defect
patterns and sizes.
An additional limitation of this study is the lack of outcomes beyond 12 months
post-ACI. However, the purpose of this study was to provide a descriptive time line for
changes in self-perceived function and functional recovery in the first year following ACI.
This time line is intended to describe when patients can expect improvements in activities
of daily living and when patients will perceive a benefit from the surgery, two key pieces
of information that may be valuable to patients and physicians when deciding if and when
to undergo ACI. Future examination of these outcome variables for a longer period (> 1
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year) will provide more information regarding the long term course of recovery following
ACI.

CONCLUSIONS
This study presents a descriptive timeline for changes in both PROs and PBAs
during the first 12 months following ACI and also describes the relationship between
PRO and PBA scores. Self-perceived changes in function were observed as early as 6
months following ACI while performance based measures of function demonstrated
functional deficits compared to preoperative levels at both the 3 and 6 month time points.
Specifically, patients demonstrated increased asymmetry of weight distribution when
squatting and longer performance times for lunging and stepping activities. At the 12
month time point performance improvements were seen for walking speed and stride
length: however, Step Up/Over time and Forward Lunge impact index and time remained
below previously reported norms. Overall, it was observed that patients’ perceptions of
functional improvements may outpace true physical changes in function. This
observation was further supported by the limited and inconsistent correlations existing
between PROs and PBAs. These results suggest that the relationship between patient’s
self ratings and physical abilities may vary over time and be largely influenced by
independent factors. Therefore, both PROs and PBAs should both be utilized to
comprehensively assess outcomes following ACI.
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CHAPTER 4: INFLUENCE OF RESPONSE SHIFT ON PATIENT REPORTED
OUTCOMES FOLLOWING AUTOLOGOUS CHONDROCYTE IMPLANTATION

INTRODUCTION
A variety of outcome measures are frequently used in clinical research to
document treatment effectiveness. While it may be possible to document changes in
clinical measures such as strength or range of motion, it is difficult to quantify abstract
concepts such as function or health related quality of life (HRQL). To assess function or
quality of life, patients are often asked to evaluate their well-being using a self-report
instrument or questionnaire to document patient reported outcomes (PROs). PROs are
used to document temporal changes such as between pre- and post-treatments. However,
PROs may be influenced by response shift.155 Response shift is the phenomenon by which
an individual’s self-evaluation of a construct changes due to a change in internal
standards of measurement (recalibration), a change in values or priorities
(reprioritization), or a personal redefinition of the target construct
(reconceptualization).163 Response shift may interfere with the ability to detect change in
a construct with accuracy. Examples of response shift are observed among the terminally
ill where patients’ physical health deteriorates, yet their self-reported HRQL remains
stable.156, 162, 181 It has been hypothesized that these changes may be a result of changing
values, standards and priorities.155 For example, patients become more focused on time
with family than work productivity. Response shift has been documented in cases of
terminal and chronic disease or illness.60, 170, 178, 181 Only three known studies have
examined response shift in an orthopedic population.10, 141, 142 In two response shift was
observed among knee arthroplasty patients 6 months and 12 months postoperatively.141,
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142

In the third, response shift was observed among articular cartilage patients undergoing

microfracture treatment.10 Based on these results, it is possible that patients undergoing
knee surgery for localized articular cartilage damage may also experience response shift.
Treatment of articular cartilage injuries represents a complex and challenging
problem for both orthopedic surgeons and rehabilitation specialists. If not treated
appropriately, defects to the hyaline cartilage can become increasingly painful and
disabling. This is particularly true for lesions of the knee where biomechanical stresses
result in both shear and compressive forces during normal activities of daily living.38
Chondral lesions have been observed in as many as 63% of knee arthroscopies; therefore,
effective treatment and rehabilitation is important.39 One of the emerging forms of
treatment for chondral defects is the use of cultured chondrocytes in the procedure known
as autologous chondrocyte implantation (ACI).28
In the twenty years since its conception ACI has been performed on thousands of
patients with degenerative and traumatic cartilage lesions.61 While early results for ACI
outcomes are promising, the existing literature primarily reports outcomes using PROs.21,
29, 31, 44, 49, 51, 86, 90, 98, 108, 115, 116, 149, 185

Although PROs are used frequently in orthopedic

and rehabilitation literature, the traditional pre-post-test research designs used may be
influenced by response shift phenomenon. If the PROs frequently used to evaluate ACI
outcomes are subject to a response shift, then reported outcomes may under- or overestimate the effectiveness of existing articular cartilage treatments. The extended
preparation and rehabilitation required for ACI may make patients undergoing this
procedure particularly prone to response shift. ACI is a two step surgical procedure.
During the first surgery a cartilage biopsy is obtained from which cells are cultured and
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then a minimum of 4 weeks later implanted into the defect during a second surgery.28 In
many cases patients have a history of prolonged knee pain and multiple previous surgeries
prior to undergoing ACI. After undergoing ACI, current rehabilitation protocols
recommend patients remain non-weight bearing for 6 to 12 weeks and maximum
improvements may not be seen until 1-2 years following surgery.143 It is possible that this
extended period of functional limitations, combined with the inherent expectations
associated with surgery, may result in a response shift.
It has been recommended that performance based assessments (PBAs) be included
in response shift studies to provide an additional reference of physical function. Schwartz
et al. suggests that differences in performance based measures and self-evaluations may
represent response shifts experienced by individuals in response to physical or emotional
changes in health.157 There is limited to no documentation of PBAs in the previous
literature regarding response shift among orthopedic knee patients.141, 142
Accurate documentation of change is vital to evaluating patient progress. If
methods of documenting change do not accurately reflect the constructs they claim to
measure then interventions intended to address those constructs cannot be accurately
evaluated. If PRO instruments used to evaluate function in ACI patients are influenced by
a response shift, then reported changes in function over time may be inaccurate. The
purpose of this study is to determine if patients undergoing ACI experience response shift.
It was proposed to verify a response shift via the then-test method and comparison to
objective PBAs. It was hypothesized that there will be evidence of a response shift using
the following PROS: the Medical Outcomes Study – 36 Item Short Form Health Survey
Physical Component Scale (SF-36 PCS), the Western Ontario and McMaster
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Osteoarthritis Index (WOMAC), and the International Knee Documentation Committee
(IKDC) Subjective Knee Evaluation Form. It was also hypothesized that outcomes
evaluated by the Lysholm Knee Scale (Lysholm) would not be influenced by response
shift. The IKDC, WOMAC, and SF-36 rely heavily on subjective evaluations of quality
of task performance, physical function, and pain levels which may be influenced by
reprioritization, recalibration, and reconceptualization. Therefore, it is anticipated that
these scales will be influenced by response shift. For example, the perception of mild
pain for someone who has had chronic pain may be recalibrated following surgical
intervention. It is not anticipate that the Lysholm scale will demonstrate a response shift
because of its focus on the capacity to perform specific tasks rather than the ease or pain
associated with task performance.

METHODS
Patients
Patients were prospectively recruited from an active cartilage center. Inclusion
criteria were the following: planned ACI surgery to the medial or lateral femoral condyle,
trochlea, or patella; willingness to participate and no uncorrectable contraindications to
ACI such as extensive degenerative joint disease, insufficient meniscus or unstable knee.
There were no exclusions based on limb malalignment if the malalignment was corrected
prior to or at the time of surgery via high tibial osteotomy or tibial tubercle transfer.
Similarly, patients undergoing concomitant or staged ligament reconstruction to correct
joint instability were also eligible for study participation. Patients undergoing
concomitant meniscal transplant were excluded.
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A total of 29 patients (17 males, 12 females, 36.3 ± 6.9 yrs, 174.4 ± 9.6 cm, 90.4 ±
19.4 kg) agreed to participate. Three patients declined to participate resulting in an
enrollment rate of 90%. Of the enrolled patients 13 underwent ACI to the patellofemoral
joint with a tibial tubercle transfer and the remaining 16 underwent ACI to the femoral
condyle, of which 4 also had a concomitant high tibial osteotomy. The mean number of
defects treated per patient was 1.38 ± 0.6 with an average treatment area of 6.6 ± 2.5 cm2
(range 2.3 to 13.0 cm2) as measured intraopteratively. All participants signed a
university approved IRB consent form.

Surgical Procedures and Rehabilitation
All patients underwent a two-step ACI procedure performed by the same surgeon
(CL). During the first procedure a limited chondroplasty was performed and the lesion
was evaluated arthroscopically. At this time a biopsy was obtained from the intracondylar
notch (100 to 200mg cartilage). This sample was sent to a commercial laboratory where
it was cultured and expanded (Carticel, Genzyme Corp, Cambridge, MA). In a second
surgical procedure chondrocyte implantation was performed using a miniarthrotomy. First the defect or defects were prepared using a curette to debride down to
the subchondral plate with stable edges. A type I/III collagen membrane (ChondroGide (R) , Geistlich Biomaterials, Wohousen, Switzerland) was shaped to match the
defect. Sutures and fibrin glue (Tisseel, Baxter Healthcare Corp., Deerfield, IL) were
used to adhere the membrane over the defect to form a water tight seal. The chondrocytes
in suspension were then injected beneath the membrane into the defect through a small
portal remaining at the edge of the collagen membrane. The portal was then closed and
sealed with sutures and additional fibrin glue.
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All patients followed standardized rehabilitation protocols following surgery.93
All patients were braced in full extension and were non-weight bearing for 2 weeks
postoperatively. Toe-touch weight bearing was permitted from 2 to 4 weeks with partial
weight bearing from 4 to 6 weeks and progression to full weight bearing between weeks 6
to 12. Continuous passive motion was prescribed for all patients for 6 to 8 hours per day
for 6 weeks. For defects in the tibiofemoral joint, knee braces were gradually unlocked
between 2 to 4 weeks as quadriceps control was gained. For defects to the patellofemoral
joint, knees were braced in full extension for weight bearing through 4 weeks
postoperative and then were gradually unlocked as quadriceps control was gained
between weeks 4 and 6. Once good quadriceps control was gained all patients were
transitioned to a hinged knee sleeve. All patients were recommended to abstain from high
intensity cutting or pivoting activity until at least 12 months post ACI.

Outcome Measures
Patient Reported Outcomes
The PROs used in this study were the SF-36 PCS,105, 106, 179 the WOMAC,18 the
IKDC,77 and the Lysholm.96 The SF-36,58 IKDC,58 Lysholm, 85 and WOMAC58, 85 have
all been evaluated for reliability among cartilage patients. The SF-36 PCS was included
to serve as measures of health related quality of life (HRQL). The IKDC and Lysholm
are region specific instruments that focus on knee function, while the WOMAC is a
disease specific instrument focusing on degenerative joint disease covering pain, stiffness,
and function. Reliability has been previously established for all of these instruments.18, 77,
85, 103, 105, 147

A researcher independent of the treating physician reviewed each instrument

with the patients and was available to answer any questions they may have had. All PROs
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were completed at the following time points: prior to implantation, 6 months, and 12
months post-surgery.

Performance Based Assessments
At each time point after completing PROs each participant completed a series of 6
PBAs in a musculoskeletal laboratory setting. All PBAs were completed using the
NeuroCom Balance Master® and long force plate (LFP) (NeuroCom International,
Clackamas, OR). This is a commercially available system designed both as a training
and evaluation tool for function and balance tasks, and it has the ability to provide
immediate feedback to clinicians and patients regarding quality of task performance for a
variety of activities of daily living (ADLs).5
The LFP consists of a 45.72 cm x 152.40 cm force plate with data sampled at 100
Hz and a personal computer equipped with data capture software (Balance Master ver.
8.1, NeuroCom International, Clackamas, OR). These functional tasks were selected
because of their direct relationship to activities of daily living and the feasibility of
patients being able to complete the task at each testing time point (Table 2.1). Tests were
completed for both testing sessions in the order presented in Table 2.1, which was
determined to be from least to most demanding based on patient reporting of difficulty
during pilot testing. All testing was administered by the same investigator (JSH). For all
single limb tests the uninvolved limb was tested first. Three successful trials of each task
were performed, except for the Weight Bearing Squat which consisted of a single trial at
each joint angle and the Rhythmic Weight Shift which consisted of one trial at each speed
in each direction. Approximately 15s of rest was provided between each trial and 30s of
rest between each task. For the purposes of this manuscript all outcome variables are
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identified using the names assigned to them by the software utilized. Definitions for these
variables are presented in Table 2.1. The six tasks are described below.

Walk Across: Patients walked across the LFP using their freely chosen standard gait speed
and pattern.
Weight Bearing Squat: Patients stood still on the force plate and the initial measure was
recorded with knee flexion angles of 0˚, 30˚, 60˚, and 90˚as tolerated 0˚). They then flexed
their knees and held positions at 30˚, 60˚, and 90˚as tolerated. The percentage of body
weight on the involved limb was measured during a single trial with a duration .01s for
each position. A standard goniometer was used to verify knee joint angle at each position.
Unilateral Stance: Patients stood on each leg and maintained their balance for 10 s with
their eyes open. They begin with the non-weight bearing leg flexed at about 60-80˚ and
with their hands on their hips. If patients touched down, or their legs touched each other,
testing was stopped and the trial was discarded. Testing of a condition was discontinued if
a participant experienced three consecutive failed trials. Testing was repeated for both
legs with the patients’ eyes closed.
Sit to Stand: Patients were seated on a 50cm box. Upon both visual and audio signals
from the computer they rose to full standing as quickly as possible without using their
hands, and then maintained a steady stance for the remainder of the 10 s trial.
Step-Up/Over: Participants stood behind a 29cm high box and stepped up onto the box
with their test leg, then brought their non-test leg up and over the box, and then stepped
down with their test leg. This was performed as quickly as possible while still maintaining
control.
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Forward Lunge: Patients in a standing position stepped forward on one leg and squatted
down as far as comfortably possible, and then returned to the initial standing position as
quickly as possible.

Assessment of Response Shift
A variety of methodological and statistical approaches have been proposed for the
measurement of response shift using self-report instruments. 8, 56, 71, 88, 109, 130, 131, 153

One

of the most common approaches is the Then-test Method (Figure 4.1).70, 71 This approach
is identical to a traditional pre-test/post-test method with the exception that subjects
complete an additional “then-test” assessment at the same session as their post-test
assessment. For the then-test subjects are instructed to assess how they were at the time
of the pre-test, prior to the intervention. The rationale for this design is that subjects will
provide responses from the same frame of reference and calibration standards to both the
then-test and the post-test by completing them at the same time. In a pre/post design
traditional change (TC) is the difference between post-test and pre-test scores and is the
only variable of interest. With the then-test method, response shift is calculated as the
difference between the then-test and the pre-test and the response shift adjusted change
(RSAC) is considered to be the difference between the post-test and the then-test.
A limitation of the then-test method is that a response shift will only be detected
on the group level if the direction of the response shift experienced is the same for the
majority of patients. A group effect for response shift has the potential to influence
overall study interpretation and may result in over or under reporting of outcomes when
only traditional change is examined and response shift is not taken into consideration.
Because numerous personal and environmental factors can influence patient perspective,
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it may be necessary to evaluate effects of response shift at the individual level. On an
individual level, response shift can influence HRQL and may be clinically relevant to the
care and management of individual patients.72 This may be particularly true in the case of
cartilage patients where few diagnostic tools are readily available to evaluate the healing
process, and subjective reporting of symptoms and perceived progress are the primary
clinical indicators of treatment outcome. In the present study response shift will also be
examined on the individual level by evaluating the magnitude of the response shift
occurring without regard for the direction.
Figure 4.1. Then-Test Method for Assessing Response Shift

Patient Reported Outcome
Score
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Response Shift (RS) = Then-test – Pre-test
Response Shift Magnitude (RSM)=absolute value of RS
Traditional Change (TC) = Post-test – Pre-test
Response Shift Adjusted Change (RSAC) = Post-test – Then-test

Response
Shift
Traditional
Change

Pre

Post

Response
Shift
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Change

Then

Evaluation

For the then-test method patients are requested to complete an outcome instrument three
times. First pre-treatment (Pre-test), again at a specified post-treatment time point (Posttest), and at that same post-treatment time point they also complete a Then-test on which
they are asked to retrospectively rate how they were at the pre-treatment time point. From
these three scores response shift, response shift magnitude, traditional change, and
response shift adjusted change can then be calculated.
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Statistical Analysis
Main Outcome Measures
The dependent variables of Response Shift, Response Shift Magnitude, Traditional
Change and Response Shift Adjusted Change were calculated for the IKDC, Lysholm, SF36 PCS and WOMAC at 6 months and 1 year following ACI as described in Figure 4.1.

Group Effect
To investigate the occurrence of a group level response shift paired t-tests were
used to compare then-test scores to pre-test scores for each instrument and to compare TC
to RSAC for each instrument. Significant t-test results would support the occurrence of a
group effect with a consistent response shift occurring across patients. A large difference
between scores would support the importance of accounting for the effects of response
shift and its potential influence on the over or under reporting of treatment effects with
traditional pre-post outcomes.

Proposed Statistical Tests to Validate Occurrence of a Group Level Response Shift
Pearson product moment correlations between PROs and PBAs were used to
evaluate the relationship between pre-test, post-test, and then-test scores for any PRO for
which a group level response shift was evident. For each PBA variable (Table 4.1) for
which a significant correlation was observed separate regression equations were
calculated to predict pre-operative PBAs from pre-test PROs and then-test PROs, and to
predict post-operative PBAs from post-test PROs. Parameter estimates (β) were then
compared using 95% confidence intervals. This process was completed at both the 6 and
12 month time points. A significant change in the relationship between self-evaluation
(PROs) and physical performance (PBAs) was considered evidence to verify that a
response shift had occurred. Because post-test PROs and then-test PROs were completed
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at the same time point postoperatively, it was anticipated that these tests would relate
similarly to PBAs (Ho: βPost = βThen). In contrast, pre-test PROs were completed prior to
surgery, prior to the occurrence of a potential response shift, resulting in a different frame
of reference and a different relationship to PBAs (Ho: βPre ≠ βPost, and βPre ≠ βThen).

Table 4.1. Linear Regressions Proposed to Verify Occurrence of a Response Shift
Regression Equations
(1) yPBA(pre) = β01 + β1xPRO(pre)
(2) yPBA(post6) = β02 + β2xPRO(post6)
(3) yPBA(post12) = β03 + β3 xPRO(post12)
(4) yPBA(pre) = β04 + β4xPRO(then6)
(5) yPBA(pre) = β05 + β5xPRO(then12)
Performance Based Assessment (PBA), Patient Reported
Outcome (PRO), Preoperative (Pre), 6 Months
Postoperative (Post6), 12 Months Postoperative (Post12),
Then-Test 6 Month Postoperative (Then6), Then-Test 12
Months Postoperative (Then12)

Individual Effect
To investigate the occurrence of an individual level effect for response shift,
response shift magnitude was calculated as the absolute value of the response shift for
each PRO. One-sample t-tests were then used to compare the response shift magnitude to
previously established minimal detectable changes (MDCs) for each PRO instrument.
The MDC at 6 and 12 month follow-up has been previously established among patients a
minimum of 5 years post ACI for the IKDC (15.6 points at 6 months, 13.7 points at 12
months), WOMAC (10.9, 15.3), and SF-36 PCS (3.2, 3.6).58 For the Lysholm scale an
MDC of 15.8 was calculated from previously published reliability and ICC values among
patients awaiting surgery for chondral defects.15, 85 Pearson product moment correlations
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were used to evaluate the relationship between response shift (Then-test – Pre-test) and
TC to determine if change in self-perceived level of function influenced response shift.

RESULTS
Six participants were declared clinical failures at or before the one year time point
and were not medically cleared to complete functional testing at all time points. An
additional five participants were lost to follow-up. Finally, one participant failed to
complete preoperative force plate testing and another participant was lost to follow-up at
the 6 month time point, but returned to the study at the 12 month time point. As a result
full PBA assessment data was only available for 16 subjects. At the 12 month time point
full PRO data was available for 22 patients including 4 patients who were declared
failures at that time point. At the 6 month time point full PRO data was available for 23
patients including 2 who were declared failures at or prior to that time point.

Group Level Analysis
Main outcome measures are reported in Table 4.2. No group level effect for
response shift was observed. There were no differences between Pre-test and Then-test
scores for any of the PROs evaluated. There were also no differences between RSAC and
TC, and none of the mean RS values exceeded previously established MDC values for the
IKDC, Lysholm, SF-36 PCS, or WOMAC. Because there was no evidence of a group
level response shift for any of the PROs, the proposed analyses involving correlation and
regression to verify response shift with functional performance were not completed.
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15.8

58

* Significantly different from MDC 6 (p = .039)
Response Shift = Then-test – Pre-test
Response Shift Magnitude = absolute value of Response Shift
Traditional Change = Post-test – Pre-test
Response Shift Adjusted Change = Post-test – Then-test

15.30

Minimal Detectable Change at 12 Months
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15.8

21 (22)
21 (15)

15 (22)
18 (20)

15 (11)
22 (22)

-6 (18)
-12 (29)

40 (18)
44 (19)

47 (18)
62 (23)
66 (23)

Lysholm
Mean (SD)

58

12.05 (25.98)
13.74 (27.28)

Response Shift Adjusted Change at 6 Months
Response Shift Adjusted Change at 12 Months
10.90

12.57 (18.36)
14.03 (17.28)

Traditional Change at 6 Months
Traditional Change at 12 Months

Minimal Detectable Change at 6 Months

12.67 (12.86)
11.37 (12.21)

Response Shift Magnitude at 6 Months
Response Shift Magnitude at 12 Months

0.52 (18.24)
1.62 (16.79)

39.92 (17.89)
40.39 (18.40)

Then-test at 6 Months
Then-test at 12 Months

Response Shift at 6 Months
Response Shift at 12 Months

39.40 (12.09)
51.97 (17.17)
54.32 (19.74

IKDC
Mean (SD)

Pre-test
Post-test 6 Months
Post-test 12 Months

Measure

58

6.6

58

8.3

5.52 (14.01)
4.35 (9.90)

6.46 (10.08)
5.65 (7.40)

6.83 (5.71)
6.91 (6.14)

0.94 (8.97)
2.28 (9.08)

37.22 (10.07)
38.31 (10.01)

36.28 (8.26)
42.74 (9.06
42.52 (10.55)

SF-36 PCS
Mean (SD)

58

15.3

58

10.9

-15 (27)
-15 (2)

-10 (17)
-12 (15)

17* (13)
15 (11)

5 (21)
-3 (19)

37 (23)
36 (20)

32 (17)
22 (19)
21 (19)

WOMAC
Mean (SD)

Table 4.2. Main Outcome Variables for Response Shift among Autologous Chondrocyte Implantation Patients

Individual Level Analysis
RSM values were used to determine the number of subjects that experienced a
response shift beyond the MDC at the 6 and 12 month time points for each PRO
instrument. At 6 months it was observed that there was a response shift beyond the MDC
for 8 patients assessed via the IKDC, 6 patients for the SF-36 PCS, 8 patients for the
Lysholm, and 15 patients for the WOMAC. At the 12 month time point 6 patients for the
IKDC, 9 patients for the SF-36 PCS, 9 patients for the Lysholm, and 8 patients for the
WOMAC experienced response shifts that exceeded the MDC. Overall 8 patients at 6
months and 4 patients at 12 months demonstrated evidence of a response shift on at least
3 of the four instruments utilized. The only PRO to show a significant response shift at an
individual level across patients was Total WOMAC score at 6 months. The mean RSM
value for the WOMAC at 6 months was 17 ± 13 which was significantly greater than the
MDC over 6 months of 10.9 established by Greco et al.58
Finally, there were no significant correlations between TC values or RS values at
6 or 12 months for any of the PROs evaluated. These results suggest that the occurrence
of a response shift is not related to overall treatment outcome as traditionally evaluated by
PROs.

DISCUSSION
Group Level Effects
The purpose of this study was to evaluate 4 common PRO instruments for
evidence of response shift in patients following ACI. Had any of those PROs
demonstrated evidence of a group level response shift, linear regression analysis would
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have been used to validate the occurrence of this response shift via comparison of selfreport and performance based outcome measures. An example of this proposed method
of analysis can be seen in Appendix B. There were no group level effects for response
shift observed for the IKDC, Lysholm, SF-36 PCS, or WOMAC. These results fail to
support the hypothesis that response shift would be evident for the IKDC, SF-36 PCS, and
WOMAC, but the results do support the hypothesis that no response shift would be
observed for the Lysholm.
Previous research in both microfracture10 and total knee arthroplasty141, 142 has
reported the occurrence of a statistically significant response shift among patients. A
significant difference between pre-test and then-test scores for the WOMAC141, 142 and the
SF-36 PCS141 has been reported at 6 and 12 months following knee arthroplasty.
Similarly, a response shift was reported using the Lysholm scale among patients a median
of 34 months following microfracture for knee articular cartilage damage.10 In both
patient populations a positive response shift was observed, meaning that patients
retrospectively rated their preoperative function lower on the then-test than they did at the
original preoperative evaluations,10, 141, 142 as a result RSAC demonstrated greater
improvement in function than TC for at least two studies.141, 142
Upon initial review our failure to observe a group level response shift is in
disagreement with the previous work10, 141, 142 in orthopaedic knee patients. However,
upon further examination the values observed in the present study are very similar to
those reported elsewhere. In the present study mean RS values of -6 ± 18 and -12 ± 29 for
the Lysholm were observed compared to a median RS of -7 (interquartile range 4 to -17)
by Balain et al.10 Similarly, mean RS values of 5 ± 21 and -3 ± 19 were observed for the
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WOMAC and 0.94 ± 8.97 and 2.28 ± 9.08 for the SF-36 PCS, compared to mean
WOMAC RS values of 3.79 ± 19.52, 5.45 ± 16.85 and 6.73 ± 15.50 and SF-36 PCS
values of -1.66 ± 8.05 and -3.16 ± 7.94 reported by Razmjou et al.141, 142 In all cases the
mean or median differences between then-test and pre-test scores were less than the
previously established MDC scores for each instrument and standard deviations or
reported ranges were quite high. However, the larger samples sizes in the previous
studies, ranging from 5310 to 234,141 resulted in statistically significant RS values, leading
the authors to conclude that a response shift had occurred. By examining actual mean RS
values and standard deviations it can be concluded that the group effect for response shift
observed in previous studies was no more clinically meaningful than those observed in the
present study. This conclusion was reiterated by the previous authors who conceded that
although a statistically significant response shift had occurred, adjusting for the response
shift did not change clinical conclusions regarding treatment efficacy.10, 141, 142 Based on
the present study and previous reports, a slight group effect for response shift may occur
among postoperative orthopaedic knee patients; however, this response shift is not
substantial enough on a group level to invalidate the use of traditional pre-post outcomes
assessment methods.

Individual Level Effect
No significant group level effect was observed for any of the PRO instruments
included in this study. However, by comparing RSM values to previously established
MDC values for articular cartilage patients a statistically significant response shift (p =
0.039) was observed on an individual level for the WOMAC at 6 months. This result
means that although WOMAC scores did not demonstrate a group level effect for
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response shift with the majority of patients recalibrating their then-test scores in a uniform
direction, the mean magnitude of change (RSM) observed on WOMAC scores did exceed
MDC values. In this study’s population, individual patients did exhibit a response shift.
However, some patients’ then-test scores recalibrated positively (Then test>Pre-test)
while others shifted negatively (Then-test< Pre-test) as a result mean RS values were not
statistically significant, but RSM values were. RS variability in magnitude and direction
were substantial enough that there was no difference in TC and RSAC values and
accounting for response shift did not alter clinical interpretation of treatment outcomes on
the group level. However, RSM values suggest that WOMAC scores are susceptible to
response shift on the individual patient level. If WOMAC scores are being used to track
treatment progress of an individual patient, response shift should be taken into
consideration.
Additional analyses using MDC values suggested that some individual patients may
experience a clinically relevant response shift across PRO instruments with 8 patients at 6
months and 4 patients at 12 months observed to have RSM values exceeding MDC values
on at least 3 out of 4 PROs. Utilizing RSM values instead of RS values provides a
depiction of the magnitude of response shift which can be examined without regard for
the direction of the response shift. The direction of the response shift is important on a
group level to evaluate the influence of response shift on interpretation of overall
treatment effects across patients. However, because it is clear that patients may
experience either a positive or negative response shift, averaging RS values across
patients may obscure the occurrence of a true, albeit non-uniform, response shift.

95

MDC values and minimal clinically important differences (MCID) were also
utilized in previous assessments of response shift in orthopaedic knee patients. Razmjou
et al. observed that 36% of patients experienced a response shift that exceeded MCID
values (15 points) for the WOMAC.141 In the present study it was observed that 65% of
patients experienced a response shift that exceeded the 6 month MDC (10.9) for the
WOMAC in articular cartilage patients. At 12 months 38% of patients experienced a
response shift exceeding the 12 month MDC (15.3) for the WOMAC. Both the present
study and previous research141 suggest that on an individual level the WOMAC may be
subject to both meaningful and measurable response shifts.
Multiple factors may contribute to the WOMAC being more influenced by
response shift than the other PROs evaluated in this study. The version of the WOMAC
included in this study consists of 24 items with 5 item Likert-type response choices.
Response choices include “none”, “mild”, “moderate”, “severe”, or “extreme”. This type
of scale can be highly subjective and may be prone to scale recalibration. Depending on
the patient’s prior experiences, mild and moderate may have different meanings over time
as the patient has more information and new experiences for comparison. While other
PRO instruments contain some similarly structured questions, the WOMAC provides
significantly less context from which the patient is asked to answer the questions. For
each of the 3 domains of the WOMAC –pain, stiffness, and function – the patient is
prompted with a simple statement such as “How much pain do you have…” or “What
degree of difficulty do you have…” followed by a list of activities or tasks such as going
up and down stairs, sitting or lying, or rising from bed. These questions do little to frame
the appraisal process. In contrast, the IKDC, SF-36, and Lysholm provide a set of
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parameters from which the patient is asked to evaluate themselves. They also may be
provided with more objective criteria for comparative rating. For example, the SF-36
instructs patients to answer questions with respect to work or daily activities (a specific
setting) in the last 4 weeks (a specific time frame) and separates physical health from
emotional health (a specific aspect of health/function). Similarly, the IKDC and the
Lysholm provide the patient with reference criteria creating meaningful standards around
which he or she can anchor his or her internal scale. For example, the IKDC asks “What
is the highest level of activity you are able to perform without significant giving way in
your knee?” and in addition to providing response choices such as “very strenuous” or
“strenuous” examples of each level of activity are provided, such as “very strenuous
activities like jumping or pivoting as in basketball or soccer.” By placing the dysfunction
of giving way in the participation context of soccer or basketball the instrument is cueing
the patient to a specific sample of relevant experiences or activities from which to
evaluate his or her own function. Finally, the Lysholm scale may be resistive to response
shift by providing objective examples of function, such as providing set distances for how
far a patient is able to walk without knee pain. The use of reference points for
comparison may reduce the likelihood of Lysholm scores being subject to scale
recalibration. By providing scale anchors and directing the patient towards a specific
sample of experiences the IKDC, SF-36, and Lysholm appear to reduce the risk of
significant variation in scale, and conceptualization between and within patients over
time.
The use of scale anchors and direction toward relevant experiences to reduce the
effect of response shift on PRO scores is consistent with Rapkin and Schwartz’s
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previously proposed model of self-appraisal for health related quality of life.139
According to this model, when faced with an assessment question a patient completes
four distinct steps to arrive at a response. The patient first establishes a frame of reference
from which to consider the question. Next, a sample of specific experiences relative to
that frame of reference is selected. These sample experiences are then judged against
subjective standards of comparison, and finally a combinatory algorithm is applied to
summarize these experiences and select a response.139 The first three steps of this process
present an area in which reconceptualization (change in initial frame of reference),
reprioritization (change in which experiences are relevant to be sampled), and
recalibration (change in standards for comparison) may occur resulting in a response shift.
By providing cues to trigger a frame of reference, referring to specific experiences to
sample, and/or providing set standards for comparison, PRO instruments may be able to
effectively reduce the influence of response shift on outcome scores, making comparisons
of scores across testing points more valid and accurate.
The WOMAC demonstrated evidence of an individual level response shift at 6
months, but not at 12 months. Performance measures and contextual factors may explain
these variations in response shift over time. As discussed in Chapter 3 of this dissertation,
there were very few differences in functional performance between preoperative and 12
month postoperative assessments. Significant changes were only observed for Walk
Across speed and Step Up/Over lift-up force. Functional capacity at preoperative and 12
month time points was similar; the relevance of this finding is that patients are likely
participating in similar activities at these time points. Furthermore, many restrictions in
activity and work have or are being removed from the patient at the 12 month time point,

98

but may still be in place at the 6 month time point. This is particularly true for those
patients involved in sports activity or manual labor. Recent activity participation, or lack
thereof, has been proposed as a potential factor contributing to response shift.40 At the 6
month time point patients have a sample of work, recreation, and physical therapy
activities from which to choose when completing the appraisal process. This sample of
experiences may be different from those available for appraisal prior to undergoing ACI
or at the 12 month time point. The removal of work and physical activity restrictions,
along with the natural healing process, may result in a very similar sample of experiences
for appraisal at the preoperative and 12 month time points. As a result, the patient may
use a similar frame of reference when completing the PROs at the preoperative and 12
month postoperative time points, resulting in little to no response shift between these time
points.
Finally, no significant correlation was observed between TC values and RS.
These results suggest that the occurrence of response shift is not a function of treatment
success as traditionally evaluated using Pre-Post PRO scores. These results are similar to
those of Balain et al. who observed no differences in any response shift variables (pretest, then-test, TC, or RSAC scores) between groups of patients with varying levels of
satisfaction following microfracture.10 These observations support the importance of
personal and environmental factors when considering response shift. The World Health
Organization’s International Classification of Functioning, Disability, and Health (ICF)
seeks to model an individuals’ health based on three principle components: body function
and structure, activity, and participation.2 However, each of these components can be
influenced by contextual factors which include both personal and environmental factors.2
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Personal and environmental factors may explain why among cartilage patients response
shift seems to be an individual and not a group phenomenon. Unlike a terminal disease,
which will inevitably impact every aspect of life, the impact of physical limitations
secondary to knee surgery may vary from person to person depending on factors such as
employment status, pre-injury activity level, self-image, social support, and preoperative
expectations. These contextual factors have previously been referred to as “antecedents”
in Spranger and Schwartz’s model of response shift and health related quality of life.163
This model of response shift stresses the importance of variables such as personality,
sociodemographics, access to care, physical environment, expectations, and spiritual
identity on health outcomes. All of these factors may vary from person to person, further
explaining the great variability in response shift observed and why evidence of a
significant response shift may exist on an individual level, but not on the group level.

Limitations
The use of the then-test method to evaluate response shift may be considered a
limitation of this study. By asking patients to recall their level of function 6 to 12 months
prior, this method may be prone to recall bias.154 However, the then-test method has
been demonstrated as having convergent validity with more complicated methods of
evaluating response shift including structural equation modeling and analysis of
covariance which require much larger samples sizes than were available in this
investigation.154, 177 Additional research has demonstrated that recall bias alone was
unable to explain changes in then-test scores observed among cancer patients, and at least
a portion of observed changes could be attributed to response shift via scale
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recalibration.157 Furthermore, use of the then-test method allowed for direct comparison
to previous investigations of response shift in orthopaedic knee patients.

CONCLUSIONS
There was no evidence of a group level effect for response shift following ACI.
These results support the validity of traditional pre-test/post-test research designs in
evaluating treatment effects following cartilage repair. Although some variations may be
observed between TC and RSAC scores for PROs, on the group level these variations are
not uniform in direction, do not exceed MDC values, and do not alter the clinical
interpretation of treatment outcomes. However, there is evidence that response shifts may
occur on an individual level on a patient by patient basis, and scores on the WOMAC in
particular may be influenced by response shifts. Future research should examine what
factors may make an individual prone to a response shift and how those factors can be
utilized to provide the individual with the highest possible self-perceived health related
quality of life. On a clinical level recognizing the occurrence of a response shift may be
key in evaluating treatment progress for individual patients. This is particularly true for
treatments such as ACI where physicians depend heavily on patient self-report and
appraisal of progress because tools for diagnostic evaluation are limited and not always
feasible or cost-effective.
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CHAPTER 5: FUNCTIONAL OUTCOMES FOLLOWING ARTICULAR
CARTILAGE IMPLANTATION: BALANCING PATIENT ORIENTED AND
PERFORMANCE BASED MEASURES

PURPOSE AND AIMS
The purposes of the presented studies were to investigate clinical and functional
outcomes following autologous chondrocyte implantation (ACI) to the knee and the
methodology for documenting those outcomes. Specifically, the following aims and
hypotheses were examined within this dissertation:
1. To systematically review and evaluate the responsiveness of common
instruments used to measure PROs following ACI at varying time points.
Hypotheses: All instruments will demonstrate improved self-reported function
and health related quality of life following ACI with the simplest instruments
showing the greatest treatment effect.
2. To determine among articular cartilage patients the reliability of the following
NeuroCom Balance Master® long force plate assessments: Walk Across,
Weight Bearing Squat, Unilateral Stance, Sit-to-Stand, Step Up/Over, and
Forward Lunge tests. Hypotheses: The reliability of all measures of time,
distance, and force will demonstrate acceptable ICC values>0.75. There will
be poor reliability of measures of sway and balance with ICC values <0.75.
3. To document the clinical outcomes of ACI patients over one year following
surgery utilizing both patient reported outcomes (PROs) and performance
based assessments (PBAs), and to examine the relationship between PROs and
PBAs. Hypotheses: All PROs and PBAs will demonstrate an initial decrease
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in function at the three month time point. There will be improved function at 6
months and improvements from baseline at the 12 month time point based on
PRO and PBA evaluations.
4. To determine if patients undergoing ACI experience a response shift between
preoperative assessment and evaluation at 6 and 12 months postoperative.
Hypotheses: There will be evidence of a response shift as assessed via PROs.
Further evidence of this response shift will be supported by changes in the
relationship between PROs and PBAs over time.

SUMMARY
Responsiveness of Patient Reported Outcomes (PROs)
In Chapter 1 the large body of work regarding the use of PROs following ACI was
reviewed. Overall the evidence supporting the use of ACI for the treatment of cartilage
defects is of poor to moderate methodological quality with included studies observed to
have a mean modified Coleman Methodology score87 of 50.9 ± 9.2. Additionally, the
majority of studies were Level 2b prospective cohorts with only 4 Level 1b randomized
controlled trials meeting the inclusion and exclusion criteria.4 Despite these limitations in
methodological quality and inconsistent reporting of outcome means and measures of
variability, a grade B4 recommendation was made for the use of the Medical Outcomes
Study 36-Item Short Form Health Survey Physical Component Scale (SF-36 PCS),105, 106,
179

the International Knee Documentation Committee Subjective Knee Form (IKDC),77

the Lysholm Knee Scale (Lysholm),96, 168 the modified Cincinnati Knee Rating System
(MCKRS),31 the Western Ontario and McMaster Universities Osteoarthritis Index
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(WOMAC),18, 19 and the Knee Injury and Osteoarthritis Outcome Score (KOOS)148 as
outcome measures following ACI.
To determine which PROs may be most receptive to changes in self-reported
function following ACI meta-analyses were conducted to examine the responsiveness of
each instrument using Hedge’s g effect sizes over 4 postoperative time points with followup ranging from less than 1 year to 4 or more years after ACI. Across all time points the
hypothesis was supported with the IKDC, KOOS, Lysholm, MCKRS, and SF-36 PCS all
demonstrating large effect sizes and significant improvement in self-reported function and
health related quality of life following ACI. There was not sufficient data to analyze the
WOMAC at any of the individual time points and limited data for the SF-36 PCS and the
MCKRS. The Lysholm was highly responsive as early as less than 1 year following ACI
and was consistently responsive throughout postoperative follow-up. However, this
instrument may not be responsive to changes in function associated with the resumption
of higher demand activities such as sports which occurs after the 1 year time point. For
the evaluation of long-term outcomes among patients who intend to return to physical
activity, this review supports the use of the IKDC which was able to detect increasing
treatment effects over time. The KOOS-sports and recreation subscale also demonstrated
increasing treatment effects over time; however, the IKDC was significantly more
responsive than this KOOS-subscale at time point II (between 1 and < 2 years post ACI)
and at time point IV (> 4 years post ACI). The use of the Lysholm and IKDC together
represents a responsive combination of PRO instruments that are able to efficiently
document both short-term and long-term treatment effects among patients of a variety of
activity levels following ACI.
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Reliability of Performance Based Assessments (PBAs)
The use of PBAs following ACI has been limited, with only a few authors
reporting functional performance for the 6 minute walk-test, the single-leg hop, and
isokinetic strength measures. 44, 45, 146, 172 In this investigation, tasks that are part of the
NeuroCom Balance Master® long force plate (LFP) (NeuroCom International, Clackamas,
OR) testing protocol were evaluated for their reliability. The examined tasks included the
Unilateral Stance, Weight Bearing Squat, Sit-to-Stand, Rhythmic Weight Shift, StepUp/Over, and the Forward Lunge. 3 These outcome measures are of low to moderate
demand, simulate activities of daily living, and are feasible for performance by ACI
patients throughout much of the recovery process. Because PBA measures should at a
minimum have the potential to be evaluated pre-operatively and at long-term (>1 year)
follow-up, a cross-sectional sample of ACI patients at the preoperative and 1 year
postoperative time point were enrolled in this study. Intraclass correlations (ICC(2,1))
were used to evaluate the test re-test reliability of each outcome measure. For unilateral
tests, only the reliability of the involved (surgical) limb was analyzed. All tests with ICC
greater than or equal to 0.75 were considered to have acceptable reliability as a PBA for
documenting outcomes following ACI.
Overall reliability varied by task, yet at least one variable for each task
demonstrated acceptable test-retest reliability. As hypothesized - force, time, and distance
measures were reliable for the Weight Bearing Squat at 90⁰, Step-Up/Over, and Lunge
with ICC values ranging from .75 to .93. Similarly, Walk Across length and speed were
also reliable; however, Walk Across width was not, nor was the Weight Bearing Squat at
0⁰, 30⁰ or, 60⁰ or Sit-to-Stand rise time or center of gravity sway velocity. Contrary to the
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hypothesis for balance measures, the Unilateral Stance demonstrated acceptable reliability
in both the eyes open (ICC = 0.75) and eyes closed (ICC = 0.77) conditions. Overall, the
selected tasks, particularly the Step Up/Over and Forward Lunge, demonstrated reliability
across a variety of levels of function among both preoperative patients and those one year
post ACI surgery. Furthermore, this study provided minimal detectable change values
(MDC) for LFP variables to evaluate longitudinal changes in function following ACI.

Application of PROs and PBAs to Evaluate Changes in Patient Function Following
ACI
As previously discussed, few studies have utilized PBAs to document the return of
function following ACI.44, 45, 146, 172 No known studies have examined the timeline for
return to function following ACI using low to moderate demand PBAs that recreate the
demands and stresses of common activities of daily living such as squatting, rising from
sitting, or going up and down stairs, in addition to walking. Nor has the relationship
between PROs and PBAs been examined in an ACI patient population. The purpose of
this study was to provide an accurate description of functional recovery during the first
year following ACI for patients, physicians and rehabilitation specialists. Furthermore, an
understanding of the relationship between PROs and PBAs provides important
information regarding the importance of collecting varying types of outcomes in future
cartilage repair research.
It was observed that patients reported significant improvements in self-reported
function on the IKDC, Lysholm, and SF-36 PCS as early as 6 months and on the
WOMAC at 12 months following ACI. However, there was an initial decrease in
function at the 3 month time point for several of the PBAs with asymmetrical weight
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distribution during squatting and increased performance time for lunging and stepping up
and over a box. At the 6 month time point performance deficits still remained, such as
asymmetrical weight distribution during squatting, but small improvements were
observed for Walk Across stride length. At the 12 month time point the only performance
variables to demonstrate changes from the preoperative time point were Walk Across
speed and stride length, and Step Up/Over lift-up index. These results support existing
theory that although improvements in self-report measures may occur early
postoperatively, maximal defect healing and functional improvement continues beyond 12
months following ACI. 22, 90, 145
Although low to moderate correlations were observed between various PROs and
PBAs at each of the 4 time points, no consistent correlations were observed between any
of the PROs and PBAs across all four time points. This inconsistent to non-existent
relationship between PROs and PBAs is consistent with previous literature concerning
orthopedic knee patients.52, 79, 82, 117, 120, 144, 159 The occurrence of changes in self-report
measures of function prior to changes in performance based measures of function may be
a result of the large influence pain levels have been observed to have on PRO scores.79, 97,
165, 166

The lack of consistent correlations between PROs and PBAs, and the observed

improvement in PRO scores in the absence of improved physical performance supports
the importance of incorporating both types of outcome measures when documenting
patient outcomes. The importance of a patient’s own rating of function and subjective
feelings towards joint health cannot be ignored. However, when considering decisions
such as ability to return to work or physical activity, or to evaluate postoperative changes
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in biomechanics, performance based measures provide unique information that cannot be
fully and accurately captured by PROs along.

The Influence of Response Shift on Patient Reported Outcomes following ACI
The final question of this dissertation examined the phenomenon of response shift
among ACI patients when evaluating outcomes using the IKDC, Lysholm, SF-36 PCS,
and KOOS. Response shift is the changing of an individual’s frame of reference or
perspective due to reprioritization, recalibration, or reconceptualization.163 If response
shift is occurring it may not be appropriate to compare PRO scores across time as a
different set of standards and a changing appraisal process is used to respond to questions
at each time point. A group level effect for response shift has the potential to result in
under or over reporting of treatment effects. On an individual level, the identification of a
response shift may be relevant to clinical care, particularly for therapies such as ACI
where self-report of changes in symptoms and pain are the primary measure of treatment
success.
Among ACI patients there was no evidence to support the hypothesis that a group
level effect for response shift would be evident in the included PROs. These results
support the validity of traditional pre-test/post-test research designs for evaluating
treatment effects following cartilage repair on the group level. However, an individual
level response shift was observed for the WOMAC at 6 months post-ACI. Response shift
magnitude values for the WOMAC at 6 months were significantly different from
previously identified MDC values. The WOMAC may be more prone to a response shift
than other PRO instruments due to its dependence on Likert–type response scales and the
failure to reference specific locations, times, or criteria that provide the patient with a
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context from which to rate his or her function. These results demonstrate that although, a
measurable response shift does not occur in a uniform direction following ACI, it does
occur on a patient-by-patient basis with some patients over-estimating their preoperative
level of function and other patients under-estimating their preoperative function.

SYNTHESIS OF RESULTS AND CONCLUSIONS
The overall purpose of this dissertation was to describe functional outcomes
following ACI and to examine the use of PROs and PBAs for evaluating functional
outcomes following ACI. From this investigation several observations and
recommendations for outcomes assessment following ACI can be made.
1. The Lysholm and the IKDC are the recommended PRO instruments for evaluating
changes in self-reported function following ACI. Both instruments exhibit
excellent responsiveness to functional changes following ACI with the Lysholm
being most responsive to short-term changes in lower level activities such, as
walking, going up and down stairs, or squatting. The IKDC demonstrated
increasing responsiveness over time as patients become eligible to return to higher
demand activities such as running or cutting. Furthermore, neither instrument was
influenced by response shift on either the group or individual level. As a result
these scores can be used for the traditional pre/post evaluation of function on a
group level, or can be used to monitor changes on a patient by patient basis.
2. Patients and clinicians can realistically anticipate significant improvements in selfreported function as early as 6 months following ACI. However, some
postoperative loss of function is likely to be present at the 3 and 6 month time
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points for movements such as stepping, lunging, and squatting. At 6 and 12
months, improvements in walking stride length can be expected, but side to side
discrepancies in performance for some activities may linger due to learned habits
or continued weakness.
3. Both PROs and PBAs are needed to create a complete picture of assessment. The
relationship between PROs and PBAs was inconsistent and varied across time.
Significant improvements in PROs were observed in the absence of substantial
changes in physical performance. PROs may be overly influenced by changes in
pain levels resulting in a poor correlation with direct physical performance, even
when instrument content addresses those tasks being performed.
4. Response shift does not substantially influence the interpretation of treatment
outcomes when using the IKDC, Lysholm or SF-36 PCS. Response shift may
influence outcomes when using the WOMAC on an individual patient level.
Although, no group effects were observed for response shift, individual patients
may experience a response shift and this potential for response shift further
supports the use of valid and reliable PBAs as an additional outcome measure
following ACI.

FUTURE RESEARCH
In this dissertation the responsiveness of several PROs was reviewed and the
reliability of a series of force plate based PBAs was established. A time line for recovery
of function following ACI using both PROs and PBAs was presented. Future research
should continue to examine the influence of factors such as defect location, defect size,
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concomitant procedures, and rehabilitation parameters (such as time non-weight bearing,
use of continuous passive motion, and intensity of strengthening activities) on both PRO
and PBA outcomes. Additionally, longer follow-up is necessary to determine if PBAs
that failed to demonstrate improvement at the 12 month time point subsequently improve
as the patient is cleared for return to regular sports and physical activity. Finally, the
relationship between preoperative or early postoperative PRO and PBA scores and longterm treatment success should be investigated to help in the selection of patients most
likely to succeed and to recognize early clinical failures and provide them with alternative
treatments.
While a significant or meaningful group level effect for response shift was not
observed in this study, a subset of patients was observed to experience response shift at
the individual level across multiple PRO instruments. This subset warrants further
considerations as response shift can be a beneficial coping mechanism in response to
disease or disability,33, 163 or it may negatively impact a person’s health related quality of
life in the event that his or her perceived expectations of treatment or self-evaluation of
function are not realistic.72 Further understanding and identification of patients prone to
response shift may improve outcomes assessment and assist in the improvement of patient
health related quality of life of patient by patient basis.
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APPENDICES
APENDIX A – PATIENT REPORTED OUTCOME INSTRUMENTS
*These pages are meant to serve as a representation of instrument content and are
formatted to fit page requirements not to serve as the actual instruments themselves.
International Knee Documentation Committee Subjective Knee Form (IKDC)
*Grade symptoms at the highest activity level at which you think you could function without significant symptoms, even
if you are not actually performing activities at this level.
1. What is the highest level of activity that you can perform without significant knee pain?
Very strenuous activities like jumping or pivoting as in basketball or soccer
Strenuous activities like heavy physical work, skiing or tennis
Moderate activities like moderate physical work, running or jogging
Light activities like walking, housework or yard work
Unable to perform any of the above activities due to knee pain
2. During the past 4 weeks, or since your injury, how often have you had pain?
Never

0

1

2

3

4

5

6

7

8

9

10

4

5

6

7

8

9

10

Constant

3. If you have pain, how severe is it?
No pain

0

1

2

3

Worst Pain
Imaginable

4. During the past 4 weeks, or since your injury, how stiff or swollen was your knee?
Not at all

Mildly

Moderately

Very

Extremely

5. What is the highest level of activity you can perform without significant swelling in your knee?
Very strenuous activities like jumping or pivoting as in basketball or soccer
Strenuous activities like heavy physical work, skiing or tennis
Moderate activities like moderate physical work, running or jogging
Light activities like walking, housework, or yard work
Unable to perform any of the above activities due to knee swelling
6. During the past 4 weeks, or since your injury, did your knee lock or catch?
Yes

No

7. What is the highest level of activity you can perform without significant giving way in your knee?
Very strenuous activities like jumping or pivoting as in basketball or soccer
Strenuous activities like heavy physical work, skiing or tennis
Moderate activities like moderate physical work, running or jogging
Light activities like walking, housework or yard work
Unable to perform any of the above activities due to giving way of the knee
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IKDC Continued.
SPORTS ACTIVITIES:
8. What is the highest level of activity you can participate in on a regular basis?
Very strenuous activities like jumping or pivoting as in basketball or soccer
Strenuous activities like heavy physical work, skiing or tennis
Moderate activities like moderate physical work, running or jogging
Light activities like walking, housework or yard work
Unable to perform any of the above activities due to knee
9. How does your knee affect your ability to:
Not difficult
at all
a.

Go up stairs

b.

Go down stairs

c.

Kneel on the front of your
knee

d.

Squat

e.

Sit with your knee bent

f.

Rise from a chair

g.

Run straight ahead

h.

Jump and land on your
involved leg

i.

Stop and start quickly

Minimally
difficult

Moderately
Difficult

Extremely
difficult

Unable
to do

FUNCTION:
10. How would you rate the function of your knee on a scale of 0 to 10 with 10 being normal, excellent function and 0
being the inability to perform any of your usual daily activities which may include sports?
FUNCTION PRIOR TO YOUR KNEE INJURY:
Cannot perform
daily activities

0

1

2

3

4

5

6

7

8

9

10

No limitation

2

3

4

5

6

7

8

9

10

No limitation

CURRENT FUNCTION OF YOUR KNEE:
Cannot perform
daily activities

0

1
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Lysholm Knee Scale

1. Do you have a limp?

7. Can you climb stairs?

No

No problems

Slight limp or limp periodically

Slightly impaired

Severe limp and constantly

One step at a time
Impossible

2. What support do you need for walking?
None

8. Can you squat?

Stick or crutch

No problems

I am unable to weight bear.

Slightly impaired
Not beyond 90 degrees

3. Does your knee lock?

Impossibl

No locking or catching sensations
Catching sensation but no locking
Locking – occasionally
Locking – frequently
Locked joint on examination (it is locked now)

4. How unstable is your Knee?
It never gives way
Rarely during athletics or other severe
exertion
Frequently during athletics
Occasionally during daily activities
Often during daily activities
Every step

5. How painful is your Knee?
No pain
Inconstant and slight during severe exertion
Marked during severe exertion
Marked on or after walking 2km
Marked on or after walking less than 2km
Constant

6. Do you have swelling in your knee?
None
On severe exertion
On ordinary exertion
Constant
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Medical Outcomes Study 36-Item Short Form Health Survey (SF-36)
1. In general, would you say your health is:
Excellent
Very Good
Good
Fair
Poor
2. Compared to one year ago, how would you rate your health in general now?
Much better now than 1 year ago
Somewhat better now than 1 year ago
About the same as 1 year ago
Somewhat worse now than 1 year ago
Much worse now than 1 year ago
3. The following questions are about activities you might do during a typical day. Does your health now limit you in
these activities?
If so, how much?
Yes, limited Yes, limited No, not limited at
a lot
a little
all
a.

Vigorous activities, such as running, lifting heavy
objects, participating in strenuous sports

b.

Moderate activities, such as moving a table, pushing a
vacuum cleaner, bowling, or playing golf

c.

Lifting or carrying groceries

d.

Climbing several flights of stairs

e.

Climbing one flight of stairs

f.

Bending, kneeling or stooping

g.

Walking more than a mile

h.

Walking several hundred yards

i.

Walking one hundred yards

j.

Bathing or dressing yourself
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SF-36 Continued
4. During the past 4 weeks, how much of the time have you had any of the following problems with your work or other
regular daily activities as a result of your physical health?
All of the
time

Most of
the time

Some of
the time

A little of
the time

None of
the time

a. Cut down on the amount of time you spent on
work or other activities
b. Accomplished less than you would like
c. Were limited in the kind of work or other
activities
d. Had difficulty performing the work or other
activities (for example, it took extra effort)
5. During the past 4 weeks, how much of the time have you had any of the following problems with your work or other
regular daily activities as a result of any emotional problems (such as feeling depressed or anxious)?
All of the
time

Most of
the time

Some of
the time

A little of
the time

None of
the time

a. Cut down on the amount of time you spent on
work or other activities
b. Accomplished less than you would like
c. Did work or other activities less carefully than usual

6. During the past 4 weeks, to what extent has your physical health or emotional problems interfered with your normal
social activities with family, friends, neighbours, or groups?
Not At All
Slightly
Moderately
Quite a Bit
Extremely
7. How much bodily pain have you had during the past 4 weeks?
None
Very Mild
Mild
Moderate
Severe
Very Severe
8. During the past 4 weeks, how much did pain interfere with your normal work (including both work outside the home and
housework)?
Not at All
A Little Bit
Moderately
Quite a Bit
Extremely
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SF-36 Continued
9. These questions are about how you feel and how things have been with you during the past 4 weeks. For each question,
please give the one answer that comes closest to the way you have been feeling. How much of the time during the past 4
weeks…
All of the Most of
time
the time

Some of
the time

A little of
the time

None of
the time

a. Did you feel full of life?
b. Have you been very nervous?
c. Have you felt so down in the dumps that nothing
could cheer you up?
d. Have you felt calm and peaceful?
e. Did you have a lot of energy?
f. Have you felt downhearted and depressed?
g. Did you feel worn out?
h. Have you been happy?
i. Did you feel tired?
10.During the past 4 weeks, how much of the time has your physical health or emotional problems interfered with your
social activities (like visiting with friends, relatives, etc.)?
All of the time
Most of the time
Some of the time
A little of the time
None of the time
11. How TRUE or FALSE is each of the following statements for you?
Definitely
True
a.

I seem to get sick a little easier than other
people

b.

I am as healthy as anybody I know

c.

I expect my health to get worse

d.

My health is excellent

.
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Mostly
True

Don’t
Know

Mostly
False

Definitely
False

Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC)
P: These questions concern the amount of pain you are currently experiencing due to arthritis in your hips
and your knees. For each situation, please enter the amount of pain you have recently experienced. How
much pain do you have...
1. Walking on a flat surface

None

Mild

Moderate

Severe

Extreme

2. Going up or down stairs

None

Mild

Moderate

Severe

Extreme

3. At night while in bed

None

Mild

Moderate

Severe

Extreme

4. Sitting or lying

None

Mild

Moderate

Severe

Extreme

5. Standing upright

None

Mild

Moderate

Severe

Extreme

M: These questions concern the amount of joint stiffness (not pain) you are currently experiencing due to arthritis in
your hips and or knees. Stiffness is sensation of restriction or slowness in the area around which you move your joints.
6. How severe is your stiffness after
first waking in the morning?

None

Mild

Moderate

Severe

Extreme

7. How severe is your stiffness after sitting,
lying or resting later in the day?

None

Mild

Moderate

Severe

Extreme

F: These questions concern your physical function. By this we mean your ability to move around and to look after
yourself. For each of the following activities please indicate the degree of difficulty you are experiencing due to
arthritis. What degree of difficulty do you have with...
8. Descending stairs

None

Mild

Moderate

Severe

Extreme

9. Ascending stairs

None

Mild

Moderate

Severe

Extreme

10. Rising from sitting

None

Mild

Moderate

Severe

Extreme

11. Standing

None

Mild

Moderate

Severe

Extreme

12. Bending to floor

None

Mild

Moderate

Severe

Extreme

13. Walking on flat

None

Mild

Moderate

Severe

Extreme

14. Getting in/out of car

None

Mild

Moderate

Severe

Extreme

15. Going shopping

None

Mild

Moderate

Severe

Extreme

16. Putting on socks/stockings

None

Mild

Moderate

Severe

Extreme

17. Rising from bed

None

Mild

Moderate

Severe

Extreme

18. Taking off socks/stockings

None

Mild

Moderate

Severe

Extreme

19. Lying in bed

None

Mild

Moderate

Severe

Extreme

20. Getting in/out bath

None

Mild

Moderate

Severe

Extreme

21. Sitting

None

Mild

Moderate

Severe

Extreme

22. Getting on/off toilet

None

Mild

Moderate

Severe

Extreme

23. Heavy domestic duties

None

Mild

Moderate

Severe

Extreme

24. Light domestic duties

None

Mild

Moderate

Severe

Extreme
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APPENDIX B: PROPOSED METHOD FOR VERIFYING RESPONSE SHIFT
WITH PERFORMANCE BASED ASSESSMENTS
In the event a group level response shift had occurred a series of linear regression
analyses would have been conducted to determine if the occurrence of the response shift
could be validated by changes in the relationship between pre-test scores and preoperative
PBAs, then-test scores and preoperative PBAs, and post-test scores and postoperative
PBAs. The purpose of this appendix is to provide an example of how this proposed
method of evaluating response shift would have been performed had there been evidence
of a response shift.
A significant correlation was observed between pre-test IKDC score and
preoperative Walk Across length (R = 0.43, p = 0.024) and between then-test at 6 months
IKDC score and preoperative Walk Across length(R = 0.43, p= 0.04). The correlation
between IKDC post-test score at 6 months and Walk Across length at 6 months was not
significant (R = 0.06, p = 0.81). Because the then-test at 6 months and post-test at 6
months were completed at the same time it was theorized that both tests would be
completed from the same frame of reference. If a response shift had occurred the
relationship between the then-test score at 6 months and preoperative Walk Across length
and the relationship between the post-test score at 6 months and 6 month Walk Across
length would be similar. However, the relationship between pre-test score and pre-test
Walk Across length would be significantly different. To evaluate these relationships a
series of regression equations were employed (Table 4.1).
The regression model for preoperative Walk Across length as a function of pretest IKDC was preoperative Walk Across length = 0.295 +.003(pre-test IKDC Score)
(Adjusted R2 = 0.15). The 95% confidence interval for the intercept was 0.199 to 0.390,
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while the confidence interval for the parameter estimate for IKDC score was 0.000 to
0.005. The regression model for preoperative Walk Across length as a function of 6
month then-test IKDC score was preoperative Walk Across length = 0.335 +.002(thentest 6month IKDC Score) (Adjusted R2 = 0.15). The 95% confidence interval for the
intercept was 0.261 to 0.410, while the confidence interval for the parameter estimate for
IKDC score was 0.000 to 0.004. Given that the 95% confidence intervals for both the
intercept and the parameter estimates overlap, these observations do not support the
occurrence of a response shift resulting in a change in patient frame of reference between
the preoperative and 6 month time points. These results are in agreement with the group
level analysis that failed to identify a response shift for the IKDC or any other PRO
instruments and fail to support the hypothesis that βPre ≠ βthen where βPre is the parameter
estimate for pre-test IKDC score and βthen is the parameter estimate for then test IKDC
score at 6 months.
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